Xiaomei Ma, PhD

• Amer Zeidan
• Andrew DeWan
• Anees Chagpar
• Brenda Cartmel
• Cary Gross
• Donna Spiegelman
• Henry S. Park
• Joseph Ross
• Jun Deng
• Kenneth B. Roberts
• Kevin Billingsley
• Krystal Pollitt
• Leah Ferrucci
• Lingeng Lu
• Marney White
• Melinda Irwin
• Michael S. Leapman
• Michaela Dinan
• Natalia Neparidze
• Nikolai Podoltsev
• Pamela L. Kunz
• Prasanna Ananth
• Preston C. Sprenkle
• Rong Wang
• Sajid A Khan
• Scott Huntington
• Shalin Kothari
• Shi-Yi Wang
• Stephanie Halene
• Stephanie Prozora
• Stuart Seropian
• Tamar Taddei
• Tarsheen Sethi
• Tormod Rogne
• Xavier Llor
• Xiao Xu

Chronic Disease; Epidemiology; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms

Aging; Cancer; Chronic Diseases; Health Policy; Maternal & Child Health

• Abstract B115: Racial and ethnic disparities in the incidence and mortality trends of acute myeloid leukemia in the United StatesKang L, Ma X, Podoltsev N, Stempel J, Wang R. Abstract B115: Racial and ethnic disparities in the incidence and mortality trends of acute myeloid leukemia in the United States. Cancer Epidemiology Biomarkers & Prevention 2023, 32: b115-b115. DOI: 10.1158/1538-7755.disp23-b115.
• State‐Level Acute Myeloid Leukemia Incidence and Mortality Trends and Association with Obesity in the United StatesKang L, Ma X, Podoltsev N, Stempel J, Wang R. State‐Level Acute Myeloid Leukemia Incidence and Mortality Trends and Association with Obesity in the United States. Blood 2023, 142: 5184. DOI: 10.1182/blood-2023-186428.
• Gene-Environment Analyses Reveal Novel Genetic Candidates with Prenatal Tobacco Exposure in Relation to Risk for Childhood Acute Lymphoblastic Leukemia.Zhong C, Li S, Arroyo K, Morimoto L, de Smith A, Metayer C, Ma X, Kogan S, Gauderman W, Wiemels J. Gene-Environment Analyses Reveal Novel Genetic Candidates with Prenatal Tobacco Exposure in Relation to Risk for Childhood Acute Lymphoblastic Leukemia. Cancer Epidemiology Biomarkers & Prevention 2023, 32: 1707-1715. PMID: 37773025, DOI: 10.1158/1055-9965.epi-23-0258.
• Evaluating genomic polygenic risk scores for childhood acute lymphoblastic leukemia in LatinosJeon S, Lo Y, Morimoto L, Metayer C, Ma X, Wiemels J, de Smith A, Chiang C. Evaluating genomic polygenic risk scores for childhood acute lymphoblastic leukemia in Latinos. Human Genetics And Genomics Advances 2023, 4: 100239. PMID: 37710962, PMCID: PMC10550840, DOI: 10.1016/j.xhgg.2023.100239.
• Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemiaPodoltsev N, Wang R, Shallis R, Stempel J, Di M, Neparidze N, Zeidan A, Huntington S, Giri S, Hull S, Gore S, Ma X. Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia. Cancer Medicine 2023, 12: 18889-18900. PMID: 37702132, PMCID: PMC10557879, DOI: 10.1002/cam4.6528.
• Assessment of proxy‐reported responses as predictors of motor and sensory peripheral neuropathy in children with B‐lymphoblastic leukemiaRodwin R, DelRocco N, Hibbitts E, Devidas M, Whitley M, Mohrmann C, Schore R, Raetz E, Winick N, Hunger S, Loh M, Hockenberry M, Ma X, Angiolillo A, Ness K, Kairalla J, Kadan‐Lottick N. Assessment of proxy‐reported responses as predictors of motor and sensory peripheral neuropathy in children with B‐lymphoblastic leukemia. Pediatric Blood & Cancer 2023, 70: e30634. PMID: 37592363, PMCID: PMC10552080, DOI: 10.1002/pbc.30634.
• Patient experiences with tissue‐based genomic testing during active surveillance for prostate cancerLeapman M, Sutherland R, Gross C, Ma X, Seibert T, Cooperberg M, Catalona W, Loeb S, Schulman‐Green D. Patient experiences with tissue‐based genomic testing during active surveillance for prostate cancer. BJUI Compass 2023, 5: 142-149. PMID: 38179031, PMCID: PMC10764160, DOI: 10.1002/bco2.277.
• Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherenceShallis R, Wang R, Zeidan A, Huntington S, Neparidze N, Stempel J, Mendez L, Di M, Ma X, Podoltsev N. Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence. Blood Advances 2023, 7: 3213-3224. PMID: 36939371, PMCID: PMC10338212, DOI: 10.1182/bloodadvances.2022009074.
• Birth characteristics and risk of Ewing sarcomaWiemels J, Wang R, Feng Q, Yee A, Morimoto L, Metayer C, Ma X. Birth characteristics and risk of Ewing sarcoma. Cancer Causes & Control 2023, 34: 837-843. PMID: 37335392, PMCID: PMC10460323, DOI: 10.1007/s10552-023-01737-4.
• Mendelian randomization study of birthweight, gestational age, and risk of childhood acute lymphoblastic leukemiaRogne T, DeWan A, Metayer C, Wiemels J, Ma X. Mendelian randomization study of birthweight, gestational age, and risk of childhood acute lymphoblastic leukemia. American Journal Of Obstetrics & Gynecology MFM 2023, 5: 101058. PMID: 37330008, DOI: 10.1016/j.ajogmf.2023.101058.
• Association between birth characteristics and incidence of pituitary adenoma and craniopharyngioma: a registry-based study in California, 2001–2015Cote D, Wang R, Morimoto L, Metayer C, Zada G, Wiemels J, Ma X. Association between birth characteristics and incidence of pituitary adenoma and craniopharyngioma: a registry-based study in California, 2001–2015. Cancer Causes & Control 2023, 34: 757-768. PMID: 37225897, PMCID: PMC10363066, DOI: 10.1007/s10552-023-01718-7.
• Parent Priorities in End-of-Life Care for Children With CancerAnanth P, Lindsay M, Mun S, McCollum S, Shabanova V, de Oliveira S, Pitafi S, Kirch R, Ma X, Gross C, Boyden J, Feudtner C, Wolfe J. Parent Priorities in End-of-Life Care for Children With Cancer. JAMA Network Open 2023, 6: e2313503. PMID: 37184834, PMCID: PMC10878399, DOI: 10.1001/jamanetworkopen.2023.13503.
• Abstract 5221: Identifying acute lymphoblastic leukemia risk loci in latino children via admixture mappingLangie J, Jeon S, Ma X, Metayer C, de Smith A, Wiemels J, Chiang C. Abstract 5221: Identifying acute lymphoblastic leukemia risk loci in latino children via admixture mapping. Cancer Research 2023, 83: 5221-5221. DOI: 10.1158/1538-7445.am2023-5221.
• PD10-01 ASSOCIATIONS BETWEEN PROSTATE MRI AND GENOMIC TESTING AND TREATMENT INTENSIFICATION AMONG PATIENTS WITH LOCALIZED PROSTATE CANCERLeapman M, Wang R, Long J, Sprenkle P, Ma X, Gross C. PD10-01 ASSOCIATIONS BETWEEN PROSTATE MRI AND GENOMIC TESTING AND TREATMENT INTENSIFICATION AMONG PATIENTS WITH LOCALIZED PROSTATE CANCER. Journal Of Urology 2023, 209: e326. DOI: 10.1097/ju.0000000000003250.01.
• Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyureaWang R, Shallis R, Stempel JM, Huntington SF, Zeidan AM, Gore SD, Ma X, Podoltsev NA. Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea. Blood Advances 2023, 7: 734-743. PMID: 35917456, PMCID: PMC9989521, DOI: 10.1182/bloodadvances.2022008259.
• “It just makes sense to me”: Patient experiences with prostate MRI during prostate cancer active surveillance.Sutherland R, Gross C, Ma X, Jeong F, Seibert T, Cooperberg M, Catalona W, Loeb S, Schulman-Green D, Leapman M. “It just makes sense to me”: Patient experiences with prostate MRI during prostate cancer active surveillance. Journal Of Clinical Oncology 2023, 41: 334-334. DOI: 10.1200/jco.2023.41.6_suppl.334.
• Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer.Leapman M, Sutherland R, Gross C, Ma X, Jeong F, Seibert T, Cooperberg M, Catalona W, Loeb S, Schulman-Green D. Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer. Journal Of Clinical Oncology 2023, 41: 333-333. DOI: 10.1200/jco.2023.41.6_suppl.333.
• Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With ObservationLeapman M, Wang R, Loeb S, Seibert T, Gaylis F, Lowentritt B, Brown G, Chen R, Lin D, Witte J, Cooperberg M, Catalona W, Gross C, Ma X. Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. Journal Of Urology 2023, 209: 710-718. PMID: 36753746, DOI: 10.1097/ju.0000000000003159.
• One-Carbon (Folate) Metabolism Pathway at Birth and Risk of Childhood Acute Lymphoblastic Leukemia: A Biomarker Study in NewbornsMetayer C, Imani P, Dudoit S, Morimoto L, Ma X, Wiemels J, Petrick L. One-Carbon (Folate) Metabolism Pathway at Birth and Risk of Childhood Acute Lymphoblastic Leukemia: A Biomarker Study in Newborns. Cancers 2023, 15: 1011. PMID: 36831356, PMCID: PMC9953980, DOI: 10.3390/cancers15041011.
• Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysisDi M, Long J, Kothari S, Sethi T, Zeidan A, Podoltsev N, Shallis R, Wang R, Ma X, Huntington S. Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis. Haematologica 2023, 108: 2218-2223. PMID: 36655436, PMCID: PMC10388284, DOI: 10.3324/haematol.2022.282252.
• Outdoor artificial light at night, air pollution, and risk of childhood acute lymphoblastic leukemia in the California Linkage Study of Early-Onset CancersZhong C, Wang R, Morimoto L, Longcore T, Franklin M, Rogne T, Metayer C, Wiemels J, Ma X. Outdoor artificial light at night, air pollution, and risk of childhood acute lymphoblastic leukemia in the California Linkage Study of Early-Onset Cancers. Scientific Reports 2023, 13: 583. PMID: 36631468, PMCID: PMC9834257, DOI: 10.1038/s41598-022-23682-z.
• Incorporation of DNA methylation quantitative trait loci (mQTLs) in epigenome-wide association analysis: application to birthweight effects in neonatal whole bloodLi S, Mancuso N, Metayer C, Ma X, de Smith A, Wiemels J. Incorporation of DNA methylation quantitative trait loci (mQTLs) in epigenome-wide association analysis: application to birthweight effects in neonatal whole blood. Clinical Epigenetics 2022, 14: 158. PMID: 36457128, PMCID: PMC9714153, DOI: 10.1186/s13148-022-01385-6.
• Racial and Ethnic Disparities in Childhood Acute Lymphoblastic Leukemia Risk Due to an IKZF1 Noncoding Regulatory Variantde Smith A, Wahlster L, Jeon S, Yu F, Black S, Gazal S, Mancuso N, Metayer C, Ma X, Wiemels J, Chiang C, Sankaran V. Racial and Ethnic Disparities in Childhood Acute Lymphoblastic Leukemia Risk Due to an IKZF1 Noncoding Regulatory Variant. Blood 2022, 140: 8880-8881. DOI: 10.1182/blood-2022-167965.
• Second Malignancies Among Older Patients with Classical Myeloproliferative Neoplasms Treated with RuxolitinibStempel J, Wang R, Shallis R, Huntington S, Zeidan A, Neparidze N, Di M, Ma X, Podoltsev N. Second Malignancies Among Older Patients with Classical Myeloproliferative Neoplasms Treated with Ruxolitinib. Blood 2022, 140: 11004-11006. DOI: 10.1182/blood-2022-165156.
• Real-World Practice Patterns and Outcomes Following Bruton Tyrosine Kinase Inhibitors (BTKi) in Older Patients with Mantle Cell Lymphoma (MCL): A Population-Based AnalysisDi M, Long J, Kothari S, Sethi T, Zeidan A, Podoltsev N, Shallis R, Wang R, Stempel J, Ma X, Huntington S. Real-World Practice Patterns and Outcomes Following Bruton Tyrosine Kinase Inhibitors (BTKi) in Older Patients with Mantle Cell Lymphoma (MCL): A Population-Based Analysis. Blood 2022, 140: 10904-10906. DOI: 10.1182/blood-2022-164959.
• Unconventional oil and gas exposure and risk of childhood leukemia in PennsylvaniaClark C, Johnson N, Soriano M, Warren J, Sorrentino K, Kadan-Lottick N, Saiers J, Ma X, Deziel N. Unconventional oil and gas exposure and risk of childhood leukemia in Pennsylvania. ISEE Conference Abstracts 2022, 2022 DOI: 10.1289/isee.2022.p-0436.
• Assessing unconventional oil and gas exposure in the Appalachian Basin: Comparison of exposure surrogates and drinking water measurements in Ohio and PennsylvaniaClark C, Xiong B, Soriano M, Gutchess K, Siegel H, Ryan E, Johnson N, Cassell K, Elliott E, Li Y, Cox A, Bugher N, Glist L, Brenneis R, Sorrentino K, Plano J, Ma X, Warren J, Plata D, Saiers J, Deziel N. Assessing unconventional oil and gas exposure in the Appalachian Basin: Comparison of exposure surrogates and drinking water measurements in Ohio and Pennsylvania. ISEE Conference Abstracts 2022, 2022 DOI: 10.1289/isee.2022.p-0833.
• Hemoglobin normalization outperforms other methods for standardizing dried blood spot metabolomics: A comparative studyJain A, Morris M, Lin EZ, Khan SA, Ma X, Deziel NC, Godri Pollitt KJ, Johnson CH. Hemoglobin normalization outperforms other methods for standardizing dried blood spot metabolomics: A comparative study. The Science Of The Total Environment 2022, 854: 158716. PMID: 36113793, DOI: 10.1016/j.scitotenv.2022.158716.
• Unconventional Oil and Gas Development Exposure and Risk of Childhood Acute Lymphoblastic Leukemia: A Case–Control Study in Pennsylvania, 2009–2017Clark CJ, Johnson NP, Soriano M, Warren JL, Sorrentino KM, Kadan-Lottick NS, Saiers JE, Ma X, Deziel NC. Unconventional Oil and Gas Development Exposure and Risk of Childhood Acute Lymphoblastic Leukemia: A Case–Control Study in Pennsylvania, 2009–2017. Environmental Health Perspectives 2022, 130: 087001. PMID: 35975995, PMCID: PMC9383266, DOI: 10.1289/ehp11092.
• Epigenome-wide association study of acute lymphoblastic leukemia in children with Down syndromeLi S, Sok P, Xu K, Muskens IS, Elliott N, Myint SS, Pandey P, Hansen HM, Morimoto LM, Kang AY, Metayer C, Ma X, Mueller BA, Roy A, Roberts I, Rabin KR, Brown AL, Lupo PJ, Wiemels JL, de Smith AJ. Epigenome-wide association study of acute lymphoblastic leukemia in children with Down syndrome. Blood Advances 2022, 6: 4132-4136. PMID: 35588500, PMCID: PMC9327551, DOI: 10.1182/bloodadvances.2022007098.
• Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic periodNeparidze N, Wang R, Zeidan AM, Podoltsev NA, Shallis RM, Ma X, Davidoff AJ, Huntington SF. Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period. Leukemia 2022, 36: 2136-2139. PMID: 35761025, PMCID: PMC9243711, DOI: 10.1038/s41375-022-01633-x.
• Interaction between maternal killer immunoglobulin-like receptors and offspring HLAs and susceptibility of childhood ALLFeng Q, Zhou M, Li S, Morimoto L, Hansen H, Myint SS, Wang R, Metayer C, Kang A, Fear AL, Pappas D, Erlich H, Hollenbach JA, Mancuso N, Trachtenberg E, de Smith AJ, Ma X, Wiemels JL. Interaction between maternal killer immunoglobulin-like receptors and offspring HLAs and susceptibility of childhood ALL. Blood Advances 2022, 6: 3756-3766. PMID: 35500222, PMCID: PMC9631572, DOI: 10.1182/bloodadvances.2021006821.
• Investigating DNA methylation as a mediator of genetic risk in childhood acute lymphoblastic leukemia.Xu K, Li S, Pandey P, Kang AY, Morimoto LM, Mancuso N, Ma X, Metayer C, Wiemels JL, de Smith AJ. Investigating DNA methylation as a mediator of genetic risk in childhood acute lymphoblastic leukemia. Human Molecular Genetics 2022, 31: 3741-3756. PMID: 35717575, PMCID: PMC9616572, DOI: 10.1093/hmg/ddac137.
• Hispanic Ethnicity Differences in Birth Characteristics, Maternal Birthplace, and Risk of Early-Onset Hodgkin Lymphoma: A Population-Based Case–Control StudyGraham C, Metayer C, Morimoto LM, Wiemels JL, Siddique A, Di M, Rodwin RL, Kadan-Lottick NS, Ma X, Wang R. Hispanic Ethnicity Differences in Birth Characteristics, Maternal Birthplace, and Risk of Early-Onset Hodgkin Lymphoma: A Population-Based Case–Control Study. Cancer Epidemiology Biomarkers & Prevention 2022, 31: 1788-1795. PMID: 35709749, PMCID: PMC9444874, DOI: 10.1158/1055-9965.epi-22-0335.
• Abstract 5882: Birth characteristics and risk of early-onset myeloproliferative neoplasms in a population-based case-control studyPodoltsev N, Wang R, Wiemels J, Morimoto L, Metayer C, Ma X. Abstract 5882: Birth characteristics and risk of early-onset myeloproliferative neoplasms in a population-based case-control study. Cancer Research 2022, 82: 5882-5882. DOI: 10.1158/1538-7445.am2022-5882.
• Accelerated epigenetic aging in newborns with Down syndromeXu K, Li S, Muskens IS, Elliott N, Myint SS, Pandey P, Hansen HM, Morimoto LM, Kang AY, Ma X, Metayer C, Mueller BA, Roberts I, Walsh KM, Horvath S, Wiemels JL, de Smith A. Accelerated epigenetic aging in newborns with Down syndrome. Aging Cell 2022, 21: e13652. PMID: 35661546, PMCID: PMC9282838, DOI: 10.1111/acel.13652.
• Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysisDi M, Cui C, Kothari S, Zeidan AM, Podoltsev NA, Neparidze N, Shallis R, Wang R, Ma X, Huntington SF. Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis. Blood Advances 2022, 6: 3339-3342. PMID: 35240689, PMCID: PMC9198937, DOI: 10.1182/bloodadvances.2021006934.
• International patterns and trends of childhood and adolescent cancer, 1978-2012Zhao Y, Sun P, Xiao J, Jin L, Ma N, Li Z, Feng G, Huang H, Deziel N, Ma X, Ni X, Zhang Y. International patterns and trends of childhood and adolescent cancer, 1978-2012. Journal Of The National Cancer Center 2022, 2: 78-89. DOI: 10.1016/j.jncc.2022.02.001.
• Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: A population-based analyses.Di M, Long J, Kothari S, Sethi T, Zeidan A, Podoltsev N, Shallis R, Wang R, Ma X, Huntington S. Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: A population-based analyses. Journal Of Clinical Oncology 2022, 40: 7554-7554. DOI: 10.1200/jco.2022.40.16_suppl.7554.
• Cytomegalovirus proteins, maternal pregnancy cytokines, and their impact on neonatal immune cytokine profiles and acute lymphoblastic leukemogenesis in children.Wiemels JL, Wang R, Zhou M, Hansen H, Gallant R, Jung J, Mancuso N, De Smith AJ, Metayer C, Kogan SC, Ma X. Cytomegalovirus proteins, maternal pregnancy cytokines, and their impact on neonatal immune cytokine profiles and acute lymphoblastic leukemogenesis in children. Haematologica 2022, 107: 2266-2270. PMID: 35638549, PMCID: PMC9425315, DOI: 10.3324/haematol.2022.280826.
• MP53-11 FOUR KALLIKREIN PANEL TESTING AMONG MEDICARE BENEFICIARIES UNDERGOING PROSTATE CANCER SCREENINGLeapman M, Long J, Wang R, Sprenkle P, Ma X, Gross C. MP53-11 FOUR KALLIKREIN PANEL TESTING AMONG MEDICARE BENEFICIARIES UNDERGOING PROSTATE CANCER SCREENING. Journal Of Urology 2022, 207: e899. DOI: 10.1097/ju.0000000000002628.11.
• Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate CancerLeapman MS, Dinan M, Pasha S, Long J, Washington SL, Ma X, Gross CP. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer. JAMA Oncology 2022, 8: 687-696. PMID: 35238879, PMCID: PMC8895315, DOI: 10.1001/jamaoncol.2021.8116.
• Parent Priorities in End-of-Life Care for Children with CancerAnanth P, Mun S, Lindsay M, De Oliveira S, Pitafi S, Ma X, Gross C, Boyden J, Feudtner C, Wolfe J. Parent Priorities in End-of-Life Care for Children with Cancer. Journal Of Pain And Symptom Management 2022, 63: 885. DOI: 10.1016/j.jpainsymman.2022.02.087.
• Physical Therapy Utilization Among Hospitalized Patients With Pediatric Acute Lymphoblastic LeukemiaRodwin RL, Ma X, Ness KK, Kadan-Lottick NS, Wang R. Physical Therapy Utilization Among Hospitalized Patients With Pediatric Acute Lymphoblastic Leukemia. JCO Oncology Practice 2022, 18: e1060-e1068. PMID: 35427182, PMCID: PMC9287366, DOI: 10.1200/op.21.00796.
• Assessing Unconventional Oil and Gas Exposure in the Appalachian Basin: Comparison of Exposure Surrogates and Residential Drinking Water MeasurementsClark CJ, Xiong B, Soriano MA, Gutchess K, Siegel HG, Ryan EC, Johnson NP, Cassell K, Elliott EG, Li Y, Cox AJ, Bugher N, Glist L, Brenneis RJ, Sorrentino KM, Plano J, Ma X, Warren JL, Plata DL, Saiers JE, Deziel NC. Assessing Unconventional Oil and Gas Exposure in the Appalachian Basin: Comparison of Exposure Surrogates and Residential Drinking Water Measurements. Environmental Science And Technology 2022, 56: 1091-1103. PMID: 34982938, PMCID: PMC10259677, DOI: 10.1021/acs.est.1c05081.
• Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer ScreeningLeapman MS, Wang R, Park H, Yu JB, Sprenkle PC, Cooperberg MR, Gross CP, Ma X. Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening. JAMA Oncology 2022, 8: 41-47. PMID: 34762100, PMCID: PMC8587214, DOI: 10.1001/jamaoncol.2021.5143.
• Oral Cyanobacteria and hepatocellular carcinomaHernandez BY, Zhu X, Risch HA, Lu L, Ma X, Irwin ML, Lim JK, Taddei TH, Pawlish KS, Stroup AM, Brown R, Wang Z, Wong LL, Yu H. Oral Cyanobacteria and hepatocellular carcinoma. Cancer Epidemiology Biomarkers & Prevention 2022, 31: cebp.epi-21-0804-a.2021. PMID: 34697061, PMCID: PMC8755591, DOI: 10.1158/1055-9965.epi-21-0804.
• Birth characteristics and risk of meningioma in a population-based study in CaliforniaCote D, Wang R, Morimoto L, Metayer C, Stempel J, Zada G, Ma X, Wiemels J. Birth characteristics and risk of meningioma in a population-based study in California. Neuro-Oncology Advances 2022, 4: vdac173. PMID: 36479059, PMCID: PMC9721385, DOI: 10.1093/noajnl/vdac173.
• Mode of Delivery, Birth Characteristics and Early-Onset Non-Hodgkin Lymphoma in a Population-Based Case-Control StudyDwyer KE, Wang R, Cozen W, Cartmel B, Wiemels JL, Morimoto LM, Metayer C, Ma X. Mode of Delivery, Birth Characteristics and Early-Onset Non-Hodgkin Lymphoma in a Population-Based Case-Control Study. Cancer Epidemiology Biomarkers & Prevention 2021, 30: cebp.0535.2021. PMID: 34548330, DOI: 10.1158/1055-9965.epi-21-0535.
• Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome‐wide association studyWang Z, Budhu AS, Shen Y, Wong LL, Hernandez BY, Tiirikainen M, Ma X, Irwin ML, Lu L, Zhao H, Lim JK, Taddei T, Mishra L, Pawlish K, Stroup A, Brown R, Nguyen MH, Koshiol J, Hernandez MO, Forgues M, Yang H, Lee M, Huang Y, Iwasaki M, Goto A, Suzuki S, Matsuda K, Tanikawa C, Kamatani Y, Mann D, Guarnera M, Shetty K, Thomas CE, Yuan J, Khor CC, Koh W, Risch H, Wang XW, Yu H. Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome‐wide association study. JGH Open 2021, 5: 1363-1372. PMID: 34950780, PMCID: PMC8674550, DOI: 10.1002/jgh3.12682.
• Proximity to endocrine-disrupting pesticides and risk of testicular germ cell tumors (TGCT) among adolescents: A population-based case-control study in CaliforniaSwartz SJ, Morimoto LM, Whitehead TP, DeRouen MC, Ma X, Wang R, Wiemels JL, McGlynn KA, Gunier R, Metayer C. Proximity to endocrine-disrupting pesticides and risk of testicular germ cell tumors (TGCT) among adolescents: A population-based case-control study in California. International Journal Of Hygiene And Environmental Health 2021, 239: 113881. PMID: 34839102, DOI: 10.1016/j.ijheh.2021.113881.
• Genome-wide trans-ethnic meta-analysis identifies novel susceptibility loci for childhood acute lymphoblastic leukemiaJeon S, de Smith AJ, Li S, Chen M, Chan TF, Muskens IS, Morimoto LM, DeWan AT, Mancuso N, Metayer C, Ma X, Wiemels JL, Chiang CWK. Genome-wide trans-ethnic meta-analysis identifies novel susceptibility loci for childhood acute lymphoblastic leukemia. Leukemia 2021, 36: 865-868. PMID: 34750507, PMCID: PMC9075725, DOI: 10.1038/s41375-021-01465-1.
• Contemporary “Real World” Molecular Testing and Tyrosine Kinase Inhibitor Adherence Patterns Among Older Pts with Chronic Myeloid Leukemia in the United StatesShallis R, Wang R, Zeidan A, Huntington S, Neparidze N, Di M, Ma X, Podoltsev N. Contemporary “Real World” Molecular Testing and Tyrosine Kinase Inhibitor Adherence Patterns Among Older Pts with Chronic Myeloid Leukemia in the United States. Blood 2021, 138: 282. DOI: 10.1182/blood-2021-151066.
• Changes in Multiple Myeloma Treatment Patterns during the Early COVID-19 Pandemic PeriodNeparidze N, Wang R, Zeidan A, Podoltsev N, Shallis R, Ma X, Davidoff A, Huntington S. Changes in Multiple Myeloma Treatment Patterns during the Early COVID-19 Pandemic Period. Blood 2021, 138: 4092. PMCID: PMC8701553, DOI: 10.1182/blood-2021-148998.
• Survival of Mantle Cell Lymphoma in the Era of Bruton Tyrosine Kinase Inhibitors: A Population-Based AnalysisDi M, Cui C, Kothari S, Zeidan A, Podoltsev N, Neparidze N, Shallis R, Wang R, Ma X, Huntington S. Survival of Mantle Cell Lymphoma in the Era of Bruton Tyrosine Kinase Inhibitors: A Population-Based Analysis. Blood 2021, 138: 182. DOI: 10.1182/blood-2021-146417.
• Epigenome-Wide Association Study of Acute Lymphoblastic Leukemia in Children with Down SyndromeLi S, Sok P, Xu K, Muskens I, Elliott N, Myint S, Pandey P, Hansen H, Morimoto L, Kang A, Metayer C, Ma X, Mueller B, Roy A, Roberts I, Rabin K, Brown A, Lupo P, Wiemels J, de Smith A. Epigenome-Wide Association Study of Acute Lymphoblastic Leukemia in Children with Down Syndrome. Blood 2021, 138: 214. DOI: 10.1182/blood-2021-151454.
• Physical Therapy Utilization Among Hospitalized Patients with Pediatric Acute Lymphoblastic LeukemiaRodwin R, Ma X, Ness K, Kadan-Lottick N, Wang R. Physical Therapy Utilization Among Hospitalized Patients with Pediatric Acute Lymphoblastic Leukemia. Blood 2021, 138: 4024. DOI: 10.1182/blood-2021-147232.
• Refining Patient-Centered Measures of End-of-Life Care Quality for Children With CancerAnanth P, Mun S, Reffat N, Kang SJ, Pitafi S, Ma X, Gross CP, Wolfe J. Refining Patient-Centered Measures of End-of-Life Care Quality for Children With Cancer. JCO Oncology Practice 2021, 18: e372-e382. PMID: 34613797, PMCID: PMC8932486, DOI: 10.1200/op.21.00447.
• Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer ManagementLeapman MS, Wang R, Park HS, Yu JB, Sprenkle PC, Dinan MA, Ma X, Gross CP. Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer Management. JAMA Network Open 2021, 4: e2128646. PMID: 34623406, PMCID: PMC8501394, DOI: 10.1001/jamanetworkopen.2021.28646.
• PD46-08 MEDIATORS OF RACIAL DISPARITY IN THE USE OF PROSTATE MRILeapman M, Dinan M, Pasha S, Washington S, Ma X, Gross C. PD46-08 MEDIATORS OF RACIAL DISPARITY IN THE USE OF PROSTATE MRI. Journal Of Urology 2021, 206: e751-e751. DOI: 10.1097/ju.0000000000002060.08.
• PD50-11 CHANGES IN PSA SCREENING RELATIVE TO THE REVISED USPSTF GUIDANCE FOR PROSTATE CANCER SCREENINGLeapman M, Wang R, Gross C, Ma X. PD50-11 CHANGES IN PSA SCREENING RELATIVE TO THE REVISED USPSTF GUIDANCE FOR PROSTATE CANCER SCREENING. Journal Of Urology 2021, 206: e856-e856. DOI: 10.1097/ju.0000000000002072.11.
• Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemiaKachuri L, Jeon S, DeWan AT, Metayer C, Ma X, Witte JS, Chiang CWK, Wiemels JL, de Smith AJ. Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia. American Journal Of Human Genetics 2021, 108: 1823-1835. PMID: 34469753, PMCID: PMC8546033, DOI: 10.1016/j.ajhg.2021.08.004.
• Outdoor artificial light at night, air pollution, and childhood acute lymphoblastic leukemiaZhong C, Wang R, Morimoto L, Longcore T, Chau K, Franklin M, Metayer C, Wiemels J, Ma X. Outdoor artificial light at night, air pollution, and childhood acute lymphoblastic leukemia. ISEE Conference Abstracts 2021, 2021 DOI: 10.1289/isee.2021.o-lt-039.
• Abstract 898: Survival for patients with early-onset colorectal cancer - An overall survival analysis from the National Cancer Database, 2004-2015Cheng E, Blackburn H, Ng K, Spiegelman D, Irwin M, Ma X, Gross C, Tabung F, Giovannucci E, Kunz P, Llor X, Billingsley K, Meyerhardt J, Ahuja N, Fuchs C. Abstract 898: Survival for patients with early-onset colorectal cancer - An overall survival analysis from the National Cancer Database, 2004-2015. Cancer Research 2021, 81: 898-898. DOI: 10.1158/1538-7445.am2021-898.
• Sociodemographic and hospital‐based predictors of intense end‐of‐life care among children, adolescents, and young adults with hematologic malignanciesMun S, Wang R, Ma X, Ananth P. Sociodemographic and hospital‐based predictors of intense end‐of‐life care among children, adolescents, and young adults with hematologic malignancies. Cancer 2021, 127: 3817-3824. PMID: 34185881, PMCID: PMC8478813, DOI: 10.1002/cncr.33764.
• Cytokine Levels at Birth in Children Who Developed Acute Lymphoblastic LeukemiaWhitehead TP, Wiemels JL, Zhou M, Kang AY, McCoy LS, Wang R, Fitch B, Petrick LM, Yano Y, Imani P, Rappaport SM, Dahl GV, Kogan SC, Ma X, Metayer C. Cytokine Levels at Birth in Children Who Developed Acute Lymphoblastic Leukemia. Cancer Epidemiology Biomarkers & Prevention 2021, 30: 1526-1535. PMID: 34078642, PMCID: PMC8338848, DOI: 10.1158/1055-9965.epi-20-1704.
• Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer DatabaseCheng E, Blackburn HN, Ng K, Spiegelman D, Irwin ML, Ma X, Gross CP, Tabung FK, Giovannucci EL, Kunz PL, Llor X, Billingsley K, Meyerhardt JA, Ahuja N, Fuchs CS. Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database. JAMA Network Open 2021, 4: e2112539. PMID: 34132794, PMCID: PMC8209612, DOI: 10.1001/jamanetworkopen.2021.12539.
• Mediators of racial disparity in the use of prostate MRI.Leapman M, Dinan M, Pasha S, Washington S, Ma X, Gross C. Mediators of racial disparity in the use of prostate MRI. Journal Of Clinical Oncology 2021, 39: 6554-6554. DOI: 10.1200/jco.2021.39.15_suppl.6554.
• Community concern and government response: Identifying socio-economic and demographic predictors of oil and gas complaints and drinking water impairments in PennsylvaniaClark CJ, Warren JL, Kadan-Lottick N, Ma X, Bell ML, Saiers JE, Deziel NC. Community concern and government response: Identifying socio-economic and demographic predictors of oil and gas complaints and drinking water impairments in Pennsylvania. Energy Research & Social Science 2021, 76: 102070. PMID: 34123731, PMCID: PMC8192069, DOI: 10.1016/j.erss.2021.102070.
• Clinical effectiveness of DNA methyltransferase inhibitors and lenalidomide in older patients with refractory anemia with ring sideroblasts: a population-based study in the United StatesWang X, Zeidan AM, Wang R, Bewersdorf JP, Zhang C, Podoltsev NA, Huntington SF, Gore SD, Ma X. Clinical effectiveness of DNA methyltransferase inhibitors and lenalidomide in older patients with refractory anemia with ring sideroblasts: a population-based study in the United States. Leukemia & Lymphoma 2021, 62: 2438-2447. PMID: 33899659, DOI: 10.1080/10428194.2021.1913142.
• YIA21-001: A Modified Delphi Study to Refine Measures of End-of-Life Care Quality for Children with CancerAnanth P, Mun S, Reffat N, Kang S, Pitafi S, Ma X, Gross C, Wolfe J. YIA21-001: A Modified Delphi Study to Refine Measures of End-of-Life Care Quality for Children with Cancer. Journal Of The National Comprehensive Cancer Network 2021, 19: yia21-001. DOI: 10.6004/jnccn.2020.7751.
• Patterns of Care for Older Patients With Myelofibrosis: A Population-based StudyMeckstroth S, Wang R, Ma X, Podoltsev N. Patterns of Care for Older Patients With Myelofibrosis: A Population-based Study. Clinical Lymphoma Myeloma & Leukemia 2021, 21: e551-e558. PMID: 33648884, DOI: 10.1016/j.clml.2021.01.025.
• The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesisMuskens IS, Li S, Jackson T, Elliot N, Hansen HM, Myint SS, Pandey P, Schraw JM, Roy R, Anguiano J, Goudevenou K, Siegmund KD, Lupo PJ, de Bruijn MFTR, Walsh KM, Vyas P, Ma X, Roy A, Roberts I, Wiemels JL, de Smith AJ. The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis. Nature Communications 2021, 12: 821. PMID: 33547282, PMCID: PMC7865055, DOI: 10.1038/s41467-021-21064-z.
• A Stakeholder-Driven Qualitative Study to Define High Quality End-of-Life Care for Children With CancerAnanth P, Mun S, Reffat N, Li R, Sedghi T, Avery M, Snaman J, Gross CP, Ma X, Wolfe J. A Stakeholder-Driven Qualitative Study to Define High Quality End-of-Life Care for Children With Cancer. Journal Of Pain And Symptom Management 2021, 62: 492-502. PMID: 33556497, PMCID: PMC8339188, DOI: 10.1016/j.jpainsymman.2021.01.134.
• Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United StatesShallis RM, Wang R, Bewersdorf JP, Zeidan AM, Davidoff AJ, Huntington SF, Podoltsev NA, Ma X. Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States. Therapeutic Advances In Hematology 2021, 12: 20406207211043404. PMID: 35154624, PMCID: PMC8832334, DOI: 10.1177/20406207211043404.
• Regional Adoption of Commercial Gene Expression Testing for Prostate CancerLeapman MS, Wang R, Ma S, Gross CP, Ma X. Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer. JAMA Oncology 2021, 7: 52-58. PMID: 33237277, PMCID: PMC7689565, DOI: 10.1001/jamaoncol.2020.6086.
• Abstract PO-125: Prenatal proximity to agricultural use of endocrine-disrupting pesticides and risk of testicular germ cell tumor (TGCT) among Latino and non-Latino adolescents in CaliforniaSwartz S, Morimoto L, Whitehead T, Gunier R, Wiemels J, Ma X, Metayer C. Abstract PO-125: Prenatal proximity to agricultural use of endocrine-disrupting pesticides and risk of testicular germ cell tumor (TGCT) among Latino and non-Latino adolescents in California. Cancer Epidemiology Biomarkers & Prevention 2020, 29: po-125-po-125. DOI: 10.1158/1538-7755.disp20-po-125.
• Contemporary Practice Patterns of Tyrosine Kinase Inhibitor Use Among Older Patients with Chronic Myeloid Leukemia in the United StatesShallis R, Wang R, Bewersdorf J, Zeidan A, Huntington S, Davidoff A, Ma X, Podoltsev N. Contemporary Practice Patterns of Tyrosine Kinase Inhibitor Use Among Older Patients with Chronic Myeloid Leukemia in the United States. Blood 2020, 136: 44-45. DOI: 10.1182/blood-2020-139531.
• Predictors of Tyrosine Kinase Inhibitor Use Among Older Patients with Chronic Myeloid Leukemia in the United StatesWang R, Shallis R, Bewersdorf J, Zeidan A, Huntington S, Ma X, Podoltsev N. Predictors of Tyrosine Kinase Inhibitor Use Among Older Patients with Chronic Myeloid Leukemia in the United States. Blood 2020, 136: 13-14. DOI: 10.1182/blood-2020-139468.
• Practice Patterns and Real-Life Outcomes for Patients with Acute Promyelocytic LeukemiaBewersdorf J, Prozora S, Wang R, Podoltsev N, Shallis R, Huntington S, Neparidze N, Ma X, Gore S, Zeidan A, Davidoff A. Practice Patterns and Real-Life Outcomes for Patients with Acute Promyelocytic Leukemia. Blood 2020, 136: 21-22. DOI: 10.1182/blood-2020-136983.
• Patterns of Care and Outcomes Among Older Patients with Myelofibrosis: A Population-Based StudyMeckstroth S, Wang R, Ma X, Podoltsev N. Patterns of Care and Outcomes Among Older Patients with Myelofibrosis: A Population-Based Study. Blood 2020, 136: 21-22. DOI: 10.1182/blood-2020-137543.
• Genetic Determinants of Blood Cell Traits Play a Role in Susceptibility to Acute Lymphoblastic LeukemiaKachuri L, Jeon S, DeWan A, Metayer C, Witte J, Ma X, Chiang C, Wiemels J, de Smith A. Genetic Determinants of Blood Cell Traits Play a Role in Susceptibility to Acute Lymphoblastic Leukemia. Blood 2020, 136: 10-11. DOI: 10.1182/blood-2020-141443.
• Diet and Risk of Myeloproliferative Neoplasms in Older Individuals from the NIH-AARP CohortPodoltsev NA, Wang X, Wang R, Hofmann JN, Liao LM, Zeidan AM, Mesa RA, Ma X. Diet and Risk of Myeloproliferative Neoplasms in Older Individuals from the NIH-AARP Cohort. Cancer Epidemiology Biomarkers & Prevention 2020, 29: 2343-2350. PMID: 32868318, PMCID: PMC8895351, DOI: 10.1158/1055-9965.epi-20-0592.
• Socioeconomic status and childhood central nervous system tumors in CaliforniaFrancis SS, Wang R, Enders C, Prado I, Wiemels JL, Ma X, Metayer C. Socioeconomic status and childhood central nervous system tumors in California. Cancer Causes & Control 2020, 32: 27-39. PMID: 33113073, DOI: 10.1007/s10552-020-01348-3.
• Birth Characteristics and Risk of Pediatric Thyroid Cancer: A Population-Based Record-Linkage Study in CaliforniaDeziel N, Zhang Y, Wang R, Wiemels JL, Morimoto L, Clark CJ, Metayer C, Ma X. Birth Characteristics and Risk of Pediatric Thyroid Cancer: A Population-Based Record-Linkage Study in California. Thyroid 2020, 31: 596-606. PMID: 32912083, PMCID: PMC8195873, DOI: 10.1089/thy.2020.0217.
• What Defines High Quality End-of-Life Care for Children with Cancer? A Stakeholder-Driven Qualitative Study (GP706)Ananth P, Mun S, Reffat N, Li R, Sedghi T, Bilodeau M, Snaman J, Gross C, Ma X, Wolfe J. What Defines High Quality End-of-Life Care for Children with Cancer? A Stakeholder-Driven Qualitative Study (GP706). Journal Of Pain And Symptom Management 2020, 60: 249. DOI: 10.1016/j.jpainsymman.2020.04.129.
• National trends in the management of patients with positive surgical margins at radical prostatectomyGhabili K, Park HS, Yu JB, Sprenkle PC, Kim SP, Nguyen KA, Ma X, Gross CP, Leapman MS. National trends in the management of patients with positive surgical margins at radical prostatectomy. World Journal Of Urology 2020, 39: 1141-1151. PMID: 32562045, DOI: 10.1007/s00345-020-03298-6.
• Abstract IA38: What causes the increased risk of acute lymphoblastic leukemia in Latinos?de Smith A, Feng Q, Walsh K, Jeon S, Morimoto L, DeWan A, Chiang C, Metayer C, Ma X, Wiemels J. Abstract IA38: What causes the increased risk of acute lymphoblastic leukemia in Latinos? Cancer Epidemiology Biomarkers & Prevention 2020, 29: ia38-ia38. DOI: 10.1158/1538-7755.disp19-ia38.
• Birth Characteristics and Risk of Early-Onset Synovial SarcomaWiemels JL, Wang R, Feng Q, Clark CJ, Amatruda JF, Rubin E, Yee AC, Morimoto LM, Metayer C, Ma X. Birth Characteristics and Risk of Early-Onset Synovial Sarcoma. Cancer Epidemiology Biomarkers & Prevention 2020, 29: 1162-1167. PMID: 32245786, PMCID: PMC7605594, DOI: 10.1158/1055-9965.epi-20-0093.
• Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex mapShallis RM, Wang R, Davidoff A, Ma X, Podoltsev NA, Zeidan AM. Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map. Blood Reviews 2020, 42: 100706. PMID: 32517877, DOI: 10.1016/j.blre.2020.100706.
• Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agentsGiri S, Huntington SF, Wang R, Zeidan AM, Podoltsev N, Gore SD, Ma X, Gross CP, Davidoff AJ, Neparidze N. Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents. Blood Advances 2020, 4: 2245-2253. PMID: 32442299, PMCID: PMC7252537, DOI: 10.1182/bloodadvances.2019001425.
• Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United StatesZeidan AM, Wang R, Wang X, Shallis RM, Podoltsev NA, Bewersdorf JP, Huntington SF, Neparidze N, Giri S, Gore SD, Davidoff AJ, Ma X. Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States. Blood Advances 2020, 4: 2192-2201. PMID: 32433746, PMCID: PMC7252544, DOI: 10.1182/bloodadvances.2020001779.
• Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United StatesZeidan AM, Podoltsev NA, Wang X, Zhang C, Bewersdorf JP, Shallis RM, Huntington SF, Neparidze N, Giri S, Gore SD, Davidoff AJ, Ma X, Wang R. Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States. Blood Advances 2020, 4: 1615-1623. PMID: 32311013, PMCID: PMC7189301, DOI: 10.1182/bloodadvances.2020001728.
• MP23-17 ASSOCIATIONS OF REGIONAL-LEVEL ADOPTION OF PROSTATE MRI AND GENOMIC TESTING AND OBSERVATION FOR PROSTATE CANCERLeapman* M, Wang R, Ma X, Gross C. MP23-17 ASSOCIATIONS OF REGIONAL-LEVEL ADOPTION OF PROSTATE MRI AND GENOMIC TESTING AND OBSERVATION FOR PROSTATE CANCER. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000856.017.
• Reply to comments on: Lifestyles and myeloproliferative neoplasms with special reference to coffee consumptionPodoltsev NA, Wang X, Wang R, Hofmann JN, Liao LM, Zeidan AM, Mesa R, Ma X. Reply to comments on: Lifestyles and myeloproliferative neoplasms with special reference to coffee consumption. International Journal Of Cancer 2020, 146: 3523-3523. PMID: 32167580, PMCID: PMC8915778, DOI: 10.1002/ijc.32974.
• Age-, sex- and disease subtype–related foetal growth differentials in childhood acute myeloid leukaemia risk: A Childhood Leukemia International Consortium analysisKaralexi MA, Dessypris N, Ma X, Spector LG, Marcotte E, Clavel J, Pombo-de-Oliveira MS, Heck JE, Roman E, Mueller BA, Hansen J, Auvinen A, Lee PC, Schüz J, Magnani C, Mora AM, Dockerty JD, Scheurer ME, Wang R, Bonaventure A, Kane E, Doody DR, Group N, Baka M, Moschovi M, Polychronopoulou S, Kourti M, Hatzipantelis E, Pelagiadis I, Dana H, Kantzanou M, Tzanoudaki M, Anastasiou T, Grenzelia M, Gavriilaki E, Sakellari I, Anagnostopoulos A, Kitra V, Paisiou A, Bouka E, Group F, Nikkilä A, Lohi O, Erdmann F, Kang A, Metayer C, Milne E, Petridou E. Age-, sex- and disease subtype–related foetal growth differentials in childhood acute myeloid leukaemia risk: A Childhood Leukemia International Consortium analysis. European Journal Of Cancer 2020, 130: 1-11. PMID: 32163883, DOI: 10.1016/j.ejca.2020.01.018.
• Spatial-Temporal Cluster Analysis of Childhood Cancer in California.Francis SS, Enders C, Hyde R, Gao X, Wang R, Ma X, Wiemels JL, Selvin S, Metayer C. Spatial-Temporal Cluster Analysis of Childhood Cancer in California. Epidemiology 2020, 31: 214-223. PMID: 31596791, PMCID: PMC9005107, DOI: 10.1097/ede.0000000000001121.
• Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control studyShen Y, Risch H, Lu L, Ma X, Irwin ML, Lim JK, Taddei T, Pawlish K, Stroup A, Brown R, Wang Z, Jia W, Wong L, Mayne ST, Yu H. Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control study. Cancer Causes & Control 2020, 31: 321-332. PMID: 32060838, PMCID: PMC7136513, DOI: 10.1007/s10552-020-01277-1.
• Lifestyle factors and risk of myeloproliferative neoplasms in the NIH‐AARP diet and health studyPodoltsev NA, Wang X, Wang R, Hofmann JN, Liao LM, Zeidan AM, Mesa R, Ma X. Lifestyle factors and risk of myeloproliferative neoplasms in the NIH‐AARP diet and health study. International Journal Of Cancer 2020, 147: 948-957. PMID: 31904114, PMCID: PMC8919268, DOI: 10.1002/ijc.32853.
• Germline cancer predisposition variants and pediatric glioma: a population-based study in CaliforniaMuskens IS, de Smith AJ, Zhang C, Hansen HM, Morimoto L, Metayer C, Ma X, Walsh KM, Wiemels JL. Germline cancer predisposition variants and pediatric glioma: a population-based study in California. Neuro-Oncology 2020, 22: 864-874. PMID: 31970404, PMCID: PMC7283023, DOI: 10.1093/neuonc/noaa014.
• Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study†Davidoff AJ, Hu X, Bewersdorf JP, Wang R, Podoltsev NA, Huntington SF, Gore SD, Ma X, Zeidan AM. Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study†. Leukemia & Lymphoma 2019, 61: 1178-1187. PMID: 31878809, PMCID: PMC7735409, DOI: 10.1080/10428194.2019.1703970.
• Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms Receiving Cytoreductive Therapy with HydroxyureaWang R, Shallis R, Huntington S, Zeidan A, Gore S, Davidoff A, Ma X, Podoltsev N. Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms Receiving Cytoreductive Therapy with Hydroxyurea. Blood 2019, 134: 330. DOI: 10.1182/blood-2019-127568.
• Clinical Outcomes of Older Patients (pts) with Acute Myeloid Leukemia (AML) Receiving Hypomethylating Agents (HMAs): A Large Population-Based Study in the United StatesZeidan A, Wang R, Wang X, Shallis R, Podoltsev N, Bewersdorf J, Huntington S, Neparidze N, Giri S, Gore S, Davidoff A, Ma X. Clinical Outcomes of Older Patients (pts) with Acute Myeloid Leukemia (AML) Receiving Hypomethylating Agents (HMAs): A Large Population-Based Study in the United States. Blood 2019, 134: 646. DOI: 10.1182/blood-2019-127398.
• Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Population-Based StudyZeidan A, Podoltsev N, Wang X, Bewersdorf J, Shallis R, Huntington S, Neparidze N, Giri S, Gore S, Ma X, Davidoff A, Wang R. Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Population-Based Study. Blood 2019, 134: 116. DOI: 10.1182/blood-2019-126643.
• Clinical Effectiveness of Hypomethylating Agents (HMAs) and Lenalidomide (Len) in Older Patients (pts) with Refractory Anemia with Ring Sideroblasts: A Large Population-Based Study in the United States (US)Wang X, Wang R, Zhang C, Zeidan A, Podoltsev N, Huntington S, Gore S, Davidoff A, Ma X. Clinical Effectiveness of Hypomethylating Agents (HMAs) and Lenalidomide (Len) in Older Patients (pts) with Refractory Anemia with Ring Sideroblasts: A Large Population-Based Study in the United States (US). Blood 2019, 134: 4748. DOI: 10.1182/blood-2019-128821.
• The Impact of the 2011 European Leukemianet (ELN) Guidelines for Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms on Therapeutic Phlebotomy and Hydroxyurea Use in Patients with Polycythemia Vera and Essential ThrombocythemiaPodoltsev N, Wang R, Shallis R, Huntington S, Zeidan A, Gore S, Davidoff A, Ma X. The Impact of the 2011 European Leukemianet (ELN) Guidelines for Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms on Therapeutic Phlebotomy and Hydroxyurea Use in Patients with Polycythemia Vera and Essential Thrombocythemia. Blood 2019, 134: 2125. DOI: 10.1182/blood-2019-127563.
• The Genome-Wide Impact of Trisomy 21 on DNA Methylation and Its Implications for Hematologic MalignanciesWiemels J, Muskens I, Li S, Pandey P, Roy R, Hansen H, Siegmund K, Mueller B, Ma X, Metayer C, de Smith A. The Genome-Wide Impact of Trisomy 21 on DNA Methylation and Its Implications for Hematologic Malignancies. Blood 2019, 134: 2510. DOI: 10.1182/blood-2019-131455.
• Immunoepidemiology of CancerMa X, Wang R. Immunoepidemiology of Cancer. 2019, 215-224. DOI: 10.1007/978-3-030-25553-4_13.
• Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agentsZeidan AM, Hu X, Zhu W, Stahl M, Wang R, Huntington SF, Giri S, Bewersdorf JP, Podoltsev NA, Gore SD, Ma X, Davidoff AJ. Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents. Leukemia & Lymphoma 2019, 61: 397-408. PMID: 31570040, PMCID: PMC7732188, DOI: 10.1080/10428194.2019.1663423.
• Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's Lymphoma.Huntington SF, Hoag JR, Wang R, Zeidan AM, Giri S, Gore SD, Ma X, Gross CP, Davidoff AJ. Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's Lymphoma. Journal Of The National Comprehensive Cancer Network 2019, 17: 1194-1202. PMID: 31590152, DOI: 10.6004/jnccn.2019.7314.
• Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population‐level analysisZeidan AM, Podoltsev NA, Wang X, Bewersdorf JP, Shallis RM, Huntington SF, Gore SD, Davidoff AJ, Ma X, Wang R. Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population‐level analysis. Cancer 2019, 125: 4241-4251. PMID: 31483484, PMCID: PMC7733320, DOI: 10.1002/cncr.32439.
• Underutilization of guideline‐recommended supportive care among older adults with multiple myeloma in the United StatesGiri S, Zhu W, Wang R, Zeidan A, Podoltsev N, Gore SD, Neparidze N, Ma X, Gross CP, Davidoff AJ, Huntington SF. Underutilization of guideline‐recommended supportive care among older adults with multiple myeloma in the United States. Cancer 2019, 125: 4084-4095. PMID: 31381151, DOI: 10.1002/cncr.32428.
• Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndromeBrown AL, de Smith AJ, Gant VU, Yang W, Scheurer ME, Walsh KM, Chernus JM, Kallsen NA, Peyton SA, Davies GE, Ehli EA, Winick N, Heerema NA, Carroll AJ, Borowitz MJ, Wood BL, Carroll WL, Raetz EA, Feingold E, Devidas M, Barcellos LF, Hansen HM, Morimoto L, Kang AY, Smirnov I, Healy J, Laverdière C, Sinnett D, Taub JW, Birch JM, Thompson P, Spector LG, Pombo-de-Oliveira MS, DeWan AT, Mullighan CG, Hunger SP, Pui CH, Loh ML, Zwick ME, Metayer C, Ma X, Mueller BA, Sherman SL, Wiemels JL, Relling MV, Yang JJ, Lupo PJ, Rabin KR. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome. Blood 2019, 134: 1227-1237. PMID: 31350265, PMCID: PMC6788009, DOI: 10.1182/blood.2018890764.
• Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndromede Smith AJ, Walsh KM, Morimoto LM, Francis SS, Hansen HM, Jeon S, Gonseth S, Chen M, Sun H, Luna-Fineman S, Antillón F, Girón V, Kang AY, Smirnov I, Shao X, Whitehead TP, Barcellos LF, Jolly KW, Healy J, Laverdière C, Sinnett D, Taub JW, Birch JM, Thompson PD, Pombo-de-Oliveira MS, Spector LG, DeWan AT, Mueller BA, Chiang C, Metayer C, Ma X, Wiemels JL. Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome. Leukemia 2019, 33: 2746-2751. PMID: 31296947, PMCID: PMC6858994, DOI: 10.1038/s41375-019-0514-9.
• Tobacco use increases risk of food insecurity: An analysis of continuous NHANES data from 1999 to 2014Mayer M, Gueorguieva R, Ma X, White MA. Tobacco use increases risk of food insecurity: An analysis of continuous NHANES data from 1999 to 2014. Preventive Medicine 2019, 126: 105765. PMID: 31260724, DOI: 10.1016/j.ypmed.2019.105765.
• Healthcare expenses for treatment of acute myeloid leukemiaBewersdorf JP, Shallis R, Wang R, Huntington S, Perreault S, Ma X, Zeidan AM. Healthcare expenses for treatment of acute myeloid leukemia. Expert Review Of Hematology 2019, 12: 641-650. PMID: 31159602, DOI: 10.1080/17474086.2019.1627869.
• RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysisZeidan AM, Zhu W, Stahl M, Wang R, Huntington SF, Giri S, Podoltsev NA, Gore SD, Ma X, Davidoff AJ. RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis. Leukemia & Lymphoma 2019, 60: 3181-3187. PMID: 31170846, DOI: 10.1080/10428194.2019.1622700.
• Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents.Giri S, Huntington S, Wang R, Zeidan A, Podoltsev N, Gore S, Ma X, Gross C, Davidoff A, Neparidze N. Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents. Journal Of Clinical Oncology 2019, 37: 8044-8044. DOI: 10.1200/jco.2019.37.15_suppl.8044.
• Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin LymphomaHuntington SF, Zhu W, Hoag JR, Wang R, Zeidan AM, Giri S, Podoltsev NA, Gore SD, Ma X, Gross CP, Davidoff AJ. Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin Lymphoma. JNCI Cancer Spectrum 2019, 3: pkz030. PMID: 31360905, PMCID: PMC6649837, DOI: 10.1093/jncics/pkz030.
• Epidemiology of acute myeloid leukemia: Recent progress and enduring challengesShallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Reviews 2019, 36: 70-87. PMID: 31101526, DOI: 10.1016/j.blre.2019.04.005.
• HGG-11. GERMLINE GENETIC PREDISPOSITION TO PEDIATRIC GLIOMAMuskens I, Walsh K, Zhang C, de Smith A, Morimoto L, Ma X, Wiemels J. HGG-11. GERMLINE GENETIC PREDISPOSITION TO PEDIATRIC GLIOMA. Neuro-Oncology 2019, 21: ii89-ii89. PMCID: PMC6477444, DOI: 10.1093/neuonc/noz036.105.
• Increased neonatal level of arginase 2 in cases of childhood acute lymphoblastic leukemia implicates immunosuppression in the etiologyNielsen AB, Zhou M, de Smith AJ, Wang R, McCoy L, Hansen H, Morimoto L, Grønbæk K, Johansen C, Kogan SC, Metayer C, Bracci PM, Ma X, Wiemels JL. Increased neonatal level of arginase 2 in cases of childhood acute lymphoblastic leukemia implicates immunosuppression in the etiology. Haematologica 2019, 104: e514-e516. PMID: 30923090, PMCID: PMC6821599, DOI: 10.3324/haematol.2019.216465.
• Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential Thrombocythemia.Podoltsev NA, Zhu M, Zeidan AM, Wang R, Wang X, Davidoff AJ, Huntington SF, Giri S, Gore SD, Ma X. Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential Thrombocythemia. Journal Of The National Comprehensive Cancer Network 2019, 17: 211-219. PMID: 30865915, DOI: 10.6004/jnccn.2018.7095.
• Parental age and the risk of childhood acute myeloid leukemia: results from the Childhood Leukemia International ConsortiumPanagopoulou P, Skalkidou A, Marcotte E, Erdmann F, Ma X, Heck JE, Auvinen A, Mueller BA, Spector LG, Roman E, Metayer C, Magnani C, Pombo-de-Oliveira MS, Scheurer ME, Mora AM, Dockerty JD, Hansen J, Kang AY, Wang R, Doody DR, Kane E, Schüz J, Christodoulakis C, Ntzani E, Petridou ET, group F, group N. Parental age and the risk of childhood acute myeloid leukemia: results from the Childhood Leukemia International Consortium. Cancer Epidemiology 2019, 59: 158-165. PMID: 30776582, PMCID: PMC7098424, DOI: 10.1016/j.canep.2019.01.022.
• AUTHOR REPLYLeapman MS, Wang R, Park HS, Yu JB, Weinreb JC, Gross CP, Ma X. AUTHOR REPLY. Urology 2019, 124: 106. PMID: 30784707, DOI: 10.1016/j.urology.2018.07.043.
• Racial Disparities in the Utilization of Recommended Supportive Care Among Patients with Multiple Myeloma in the United StatesGiri S, Zhu W, Wang R, Zeidan A, Podoltsev N, Gore S, Ma X, Davidoff A, Huntington S. Racial Disparities in the Utilization of Recommended Supportive Care Among Patients with Multiple Myeloma in the United States. Blood 2018, 132: 978. DOI: 10.1182/blood-2018-99-119791.
• Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Polycythemia Vera: A Population-Based StudyPodoltsev N, Zhu M, Wang R, Zeidan A, Wang X, Davidoff A, Huntington S, Giri S, Gore S, Ma X. Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Polycythemia Vera: A Population-Based Study. Blood 2018, 132: 3580. DOI: 10.1182/blood-2018-99-119272.
• Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based StudyPodoltsev N, Zhu M, Wang R, Zeidan A, Wang X, Huntington S, Giri S, Davidoff A, Gore S, Ma X. Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based Study. Blood 2018, 132: 4865. DOI: 10.1182/blood-2018-99-119118.
• Transfusion Independence in Lower-Risk, Non-del5(q) Myelodysplastic Syndromes (LR-MDS) Among Patients (pts) Initiating Hypomethylating Agents (HMAs) While Receiving Red Blood Cell (RBC) TransfusionsZeidan A, Zhu W, Wang R, Stahl M, Huntington S, Giri S, Podoltsev N, Gore S, Ma X, Davidoff A. Transfusion Independence in Lower-Risk, Non-del5(q) Myelodysplastic Syndromes (LR-MDS) Among Patients (pts) Initiating Hypomethylating Agents (HMAs) While Receiving Red Blood Cell (RBC) Transfusions. Blood 2018, 132: 838. DOI: 10.1182/blood-2018-99-116497.
• Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET UtilityHuntington S, Zhu W, Hoag J, Wang R, Zeidan A, Giri S, Podoltsev N, Gore S, Ma X, Gross C, Davidoff A. Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility. Blood 2018, 132: 3538. DOI: 10.1182/blood-2018-99-115140.
• Does Provider Experience Treating Patients (pts) with Myelodysplastic Syndromes (MDS) Explain Duration of Hypomethylating Agent (HMA) Therapy and Overall Survival (OS)? A Large Population-Based AnalysisZeidan A, Hu X, Zhu W, Stahl M, Giri S, Huntington S, Wang R, Podoltsev N, Gore S, Ma X, Davidoff A. Does Provider Experience Treating Patients (pts) with Myelodysplastic Syndromes (MDS) Explain Duration of Hypomethylating Agent (HMA) Therapy and Overall Survival (OS)? A Large Population-Based Analysis. Blood 2018, 132: 370. DOI: 10.1182/blood-2018-99-111052.
• PDTM-01. GERMLINE GENETIC PREDISPOSITION TO PEDIATRIC GLIOMAMuskens I, Walsh K, de Smith A, Morimoto L, Metayer C, Ma X, Wiemels J. PDTM-01. GERMLINE GENETIC PREDISPOSITION TO PEDIATRIC GLIOMA. Neuro-Oncology 2018, 20: vi203-vi203. PMCID: PMC6217152, DOI: 10.1093/neuonc/noy148.843.
• The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia veraPodoltsev NA, Zhu M, Zeidan AM, Wang R, Wang X, Davidoff AJ, Huntington SF, Giri S, Gore SD, Ma X. The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera. Blood Advances 2018, 2: 2681-2690. PMID: 30333100, PMCID: PMC6199652, DOI: 10.1182/bloodadvances.2018021436.
• BMI1 enhancer polymorphism underlies chromosome 10p12.31 association with childhood acute lymphoblastic leukemiade Smith AJ, Walsh KM, Francis SS, Zhang C, Hansen HM, Smirnov I, Morimoto L, Whitehead TP, Kang A, Shao X, Barcellos LF, McKean‐Cowdin R, Zhang L, Fu C, Wang R, Yu H, Hoh J, Dewan AT, Metayer C, Ma X, Wiemels JL. BMI1 enhancer polymorphism underlies chromosome 10p12.31 association with childhood acute lymphoblastic leukemia. International Journal Of Cancer 2018, 143: 2647-2658. PMID: 29923177, PMCID: PMC6235695, DOI: 10.1002/ijc.31622.
• Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming itZeidan AM, Shallis RM, Wang R, Davidoff A, Ma X. Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it. Blood Reviews 2018, 34: 1-15. PMID: 30314642, DOI: 10.1016/j.blre.2018.09.001.
• Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphomaHuntington SF, Hoag JR, Zhu W, Wang R, Zeidan AM, Giri S, Podoltsev NA, Gore SD, Ma X, Gross CP, Davidoff AJ. Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma. Cancer 2018, 124: 4211-4220. PMID: 30216436, PMCID: PMC6263848, DOI: 10.1002/cncr.31688.
• A community-based evaluation of proximity to unconventional oil and gas wells, drinking water contaminants, and health symptoms in OhioElliott EG, Ma X, Leaderer BP, McKay LA, Pedersen CJ, Wang C, Gerber CJ, Wright TJ, Sumner AJ, Brennan M, Silva GS, Warren JL, Plata DL, Deziel NC. A community-based evaluation of proximity to unconventional oil and gas wells, drinking water contaminants, and health symptoms in Ohio. Environmental Research 2018, 167: 550-557. PMID: 30145431, DOI: 10.1016/j.envres.2018.08.022.
• Prostate cancer risk factors in black and white men in the NIH-AARP Diet and Health StudyLayne TM, Graubard BI, Ma X, Mayne ST, Albanes D. Prostate cancer risk factors in black and white men in the NIH-AARP Diet and Health Study. Prostate Cancer And Prostatic Diseases 2018, 22: 91-100. PMID: 30108373, PMCID: PMC6676904, DOI: 10.1038/s41391-018-0070-9.
• Association Between Prostate Magnetic Resonance Imaging and Observation for Low-risk Prostate CancerLeapman MS, Wang R, Park HS, Yu JB, Weinreb JC, Gross CP, Ma X. Association Between Prostate Magnetic Resonance Imaging and Observation for Low-risk Prostate Cancer. Urology 2018, 124: 98-106. PMID: 30107188, DOI: 10.1016/j.urology.2018.07.041.
• Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United StatesMa X, Steensma DP, Scott BL, Kiselev P, Sugrue MM, Swern AS. Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States. BMJ Open 2018, 8: e019955. PMID: 30037860, PMCID: PMC6059277, DOI: 10.1136/bmjopen-2017-019955.
• Abstract 3241: Children with acute lymphoblastic leukemia have increased arginase 2 at birth, implicating immunosuppression in leukemogenesisNielsen A, Zhou M, Smith A, McCoy L, Hansen H, Bracci P, Morimoto L, Kogan S, Metayer C, Ma X, Wiemels J. Abstract 3241: Children with acute lymphoblastic leukemia have increased arginase 2 at birth, implicating immunosuppression in leukemogenesis. Cancer Research 2018, 78: 3241-3241. DOI: 10.1158/1538-7445.am2018-3241.
• Regional Practice Patterns and Racial/Ethnic Differences in Intensity of End‐of‐Life CareWang S, Hsu SH, Huang S, Doan KC, Gross CP, Ma X. Regional Practice Patterns and Racial/Ethnic Differences in Intensity of End‐of‐Life Care. Health Services Research 2018, 53: 4291-4309. PMID: 29951996, PMCID: PMC6232508, DOI: 10.1111/1475-6773.12998.
• Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?Zeidan AM, Stahl M, DeVeaux M, Giri S, Huntington S, Podoltsev N, Wang R, Ma X, Davidoff AJ, Gore SD. Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates? Blood Cancer Journal 2018, 8: 55. PMID: 29891916, PMCID: PMC5995881, DOI: 10.1038/s41408-018-0081-8.
• Randomized Trial of the Impact of Empowering Childhood Cancer Survivors With Survivorship Care PlansKadan-Lottick NS, Ross WL, Mitchell HR, Rotatori J, Gross CP, Ma X. Randomized Trial of the Impact of Empowering Childhood Cancer Survivors With Survivorship Care Plans. Journal Of The National Cancer Institute 2018, 110: 1352-1359. PMID: 29771337, DOI: 10.1093/jnci/djy057.
• Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International ConsortiumPetridou ET, Georgakis MK, Erdmann F, Ma X, Heck JE, Auvinen A, Mueller BA, Spector LG, Roman E, Metayer C, Magnani C, Pombo-de-Oliveira MS, Ezzat S, Scheurer ME, Mora AM, Dockerty JD, Hansen J, Kang AY, Wang R, Doody DR, Kane E, Rashed WM, Dessypris N, Schüz J, Infante-Rivard C, Skalkidou A. Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium. European Journal Of Epidemiology 2018, 33: 965-976. PMID: 29761423, PMCID: PMC6384148, DOI: 10.1007/s10654-018-0402-z.
• Physician peer group characteristics and timeliness of breast cancer surgeryBachand J, Soulos PR, Herrin J, Pollack CE, Xu X, Ma X, Gross CP. Physician peer group characteristics and timeliness of breast cancer surgery. Breast Cancer Research And Treatment 2018, 170: 657-665. PMID: 29693229, PMCID: PMC6048589, DOI: 10.1007/s10549-018-4789-8.
• Lung Nodule Detection via Deep Reinforcement LearningAli I, Hart GR, Gunabushanam G, Liang Y, Muhammad W, Nartowt B, Kane M, Ma X, Deng J. Lung Nodule Detection via Deep Reinforcement Learning. Frontiers In Oncology 2018, 8: 108. PMID: 29713615, PMCID: PMC5912002, DOI: 10.3389/fonc.2018.00108.
• MP53-08 USE OF PROSTATE MAGNETIC RESONANCE IMAGING AMONG MEDICARE BENEFICIARIES WITH LOW-RISK PROSTATE CANCER IS ASSOCIATED WITH A HIGHER LIKELIHOOD OF DEFINITIVE TREATMENTLeapman M, Wang R, Park H, Yu J, Gross C, Ma X. MP53-08 USE OF PROSTATE MAGNETIC RESONANCE IMAGING AMONG MEDICARE BENEFICIARIES WITH LOW-RISK PROSTATE CANCER IS ASSOCIATED WITH A HIGHER LIKELIHOOD OF DEFINITIVE TREATMENT. Journal Of Urology 2018, 199: e707. DOI: 10.1016/j.juro.2018.02.1679.
• Neonatal Hormone Concentrations and Risk of Testicular Germ Cell Tumors (TGCT)Morimoto LM, Zava D, McGlynn KA, Stanczyk FZ, Kang AY, Ma X, Wiemels JL, Metayer C. Neonatal Hormone Concentrations and Risk of Testicular Germ Cell Tumors (TGCT). Cancer Epidemiology Biomarkers & Prevention 2018, 27: 488-495. PMID: 29475970, PMCID: PMC5884718, DOI: 10.1158/1055-9965.epi-17-0879.
• Residential Proximity to Unconventional Oil and Gas Wells, Drinking Water Contaminants, and Health Symptoms in the Ohio Utica Shale FormationElliott E, Ma X, Plata D, Leaderer B, McKay L, Pedersen C, Wang C, Gerber C, Wright T, Brennan M, Deziel N. Residential Proximity to Unconventional Oil and Gas Wells, Drinking Water Contaminants, and Health Symptoms in the Ohio Utica Shale Formation. ISEE Conference Abstracts 2018, 2017 DOI: 10.1289/isee.2017.2017-1058.
• GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21Wiemels JL, Walsh KM, de Smith AJ, Metayer C, Gonseth S, Hansen HM, Francis SS, Ojha J, Smirnov I, Barcellos L, Xiao X, Morimoto L, McKean-Cowdin R, Wang R, Yu H, Hoh J, DeWan AT, Ma X. GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21. Nature Communications 2018, 9: 286. PMID: 29348612, PMCID: PMC5773513, DOI: 10.1038/s41467-017-02596-9.
• Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantationZeidan AM, Stahl M, Hu X, Wang R, Huntington SF, Podoltsev NA, Gore SD, Ma X, Davidoff AJ. Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation. Blood 2017, 131: 818-821. PMID: 29259002, PMCID: PMC6410557, DOI: 10.1182/blood-2017-10-811729.
• Regional Medicare Expenditures and Survival Among Older Women With Localized Breast CancerTannenbaum S, Soulos PR, Herrin J, Mougalian S, Long JB, Wang R, Ma X, Gross CP, Xu X. Regional Medicare Expenditures and Survival Among Older Women With Localized Breast Cancer. Medical Care 2017, 55: 1030-1038. PMID: 29068906, PMCID: PMC5863278, DOI: 10.1097/mlr.0000000000000822.
• A germ-line deletion of APOBEC3B does not contribute to subtype-specific childhood acute lymphoblastic leukemia etiologyWallace AD, Francis SS, Shao X, de Smith AJ, Walsh KM, Mckean-Cowdin R, Ma X, Dahl G, Barcellos LF, Wiemels JL, Metayer C. A germ-line deletion of APOBEC3B does not contribute to subtype-specific childhood acute lymphoblastic leukemia etiology. Haematologica 2017, 103: e29-e31. PMID: 29025908, PMCID: PMC5777211, DOI: 10.3324/haematol.2017.179317.
• Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based studyZeidan AM, Long JB, Wang R, Hu X, Yu JB, Huntington SF, Abel GA, Mougalian SS, Podoltsev NA, Gore SD, Gross CP, Ma X, Davidoff AJ. Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study. PLOS ONE 2017, 12: e0184747. PMID: 28902882, PMCID: PMC5597231, DOI: 10.1371/journal.pone.0184747.
• Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of LifeWang R, Zeidan AM, Halene S, Xu X, Davidoff AJ, Huntington SF, Podoltsev NA, Gross CP, Gore SD, Ma X. Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life. Journal Of Clinical Oncology 2017, 35: jco.2017.72.714. PMID: 28783450, PMCID: PMC5648174, DOI: 10.1200/jco.2017.72.7149.
• Abstract 2263: Neonatal hormone levels and risk of testicular germ cell tumors (TGCT)Morimoto L, Zava D, McGlynn K, Stanczyk F, Wiemels J, Ma X, Metayer C. Abstract 2263: Neonatal hormone levels and risk of testicular germ cell tumors (TGCT). Cancer Research 2017, 77: 2263-2263. DOI: 10.1158/1538-7445.am2017-2263.
• Abstract 1273: Pathway analysis of insulin-like growth factor candidate genes and risk of pediatric rhabdomyosarcomaMorimoto L, Shao X, Chokkalingam A, Wiemels J, Ma X, Metayer C. Abstract 1273: Pathway analysis of insulin-like growth factor candidate genes and risk of pediatric rhabdomyosarcoma. Cancer Research 2017, 77: 1273-1273. DOI: 10.1158/1538-7445.am2017-1273.
• Cost‐effectiveness analysis of consolidation with brentuximab vedotin for high‐risk Hodgkin lymphoma after autologous stem cell transplantationHui L, von Keudell G, Wang R, Zeidan AM, Gore SD, Ma X, Davidoff AJ, Huntington SF. Cost‐effectiveness analysis of consolidation with brentuximab vedotin for high‐risk Hodgkin lymphoma after autologous stem cell transplantation. Cancer 2017, 123: 3763-3771. PMID: 28640385, PMCID: PMC5610636, DOI: 10.1002/cncr.30818.
• Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population‐based studyZeidan AM, Hu X, Long JB, Wang R, Ma X, Podoltsev NA, Huntington SF, Gore SD, Davidoff AJ. Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population‐based study. Cancer 2017, 123: 3754-3762. PMID: 28621841, PMCID: PMC6540984, DOI: 10.1002/cncr.30814.
• Survivorship Care Preferences: A Pilot Study of Young Adults With CancerViola A, Mitchell HR, Salner A, Gillan E, Rotatori J, Cartmel B, Santacroce S, Ma X, Kadan-Lottick N. Survivorship Care Preferences: A Pilot Study of Young Adults With Cancer. Clinical Journal Of Oncology Nursing 2017, 21: e71-e78. PMID: 29658261, DOI: 10.1188/17.cjon.e71-e78.
• Parental Age and Risk of Pediatric Cancer in the Offspring: A Population-Based Record-Linkage Study in CaliforniaWang R, Metayer C, Morimoto L, Wiemels JL, Yang J, DeWan AT, Kang A, Ma X. Parental Age and Risk of Pediatric Cancer in the Offspring: A Population-Based Record-Linkage Study in California. American Journal Of Epidemiology 2017, 186: 843-856. PMID: 28535175, PMCID: PMC5860074, DOI: 10.1093/aje/kwx160.
• Hypomethylating agent (HMA) therapy use and survival in older patients with higher risk myelodysplastic syndromes (HR-MDS) in the United States (USA): A large population-based study.Zeidan A, Hu X, Long J, Wang R, Huntington S, Podoltsev N, Giri S, Stahl M, Gore S, Ma X, Davidoff A. Hypomethylating agent (HMA) therapy use and survival in older patients with higher risk myelodysplastic syndromes (HR-MDS) in the United States (USA): A large population-based study. Journal Of Clinical Oncology 2017, 35: 7057-7057. DOI: 10.1200/jco.2017.35.15_suppl.7057.
• Physician volume and discontinuation of rituximab during lymphoma treatment.Huntington S, Long J, Hoag J, Wang R, Zeidan A, Giri S, Gore S, Ma X, Gross C, Davidoff A. Physician volume and discontinuation of rituximab during lymphoma treatment. Journal Of Clinical Oncology 2017, 35: 6593-6593. DOI: 10.1200/jco.2017.35.15_suppl.6593.
• Serum 25‐hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black menLayne TM, Weinstein SJ, Graubard BI, Ma X, Mayne ST, Albanes D. Serum 25‐hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men. Cancer 2017, 123: 2698-2704. PMID: 28369777, PMCID: PMC5498231, DOI: 10.1002/cncr.30634.
• 32 Hypomethylating Agent Therapy use and Survival in Older Patients with Chronic Myelomonocytic Leukemia in USA: A Large Population-Based StudyZeidan A, Hu X, Long J, Wang R, Ma X, Podoltsev N, Huntington S, Gore S, Davidoff A. 32 Hypomethylating Agent Therapy use and Survival in Older Patients with Chronic Myelomonocytic Leukemia in USA: A Large Population-Based Study. Leukemia Research 2017, 55: s20-s21. DOI: 10.1016/s0145-2126(17)30145-5.
• 121 Hypomethylating Agent Therapy Use and Survival in Older Patients with Higher Risk Myelodysplastic Syndromes in USA: A Large Population-Based StudyZeidan A, Hu X, Long J, Wang R, Huntington S, Podoltsev N, Giri S, Stahl M, Gore S, Ma X, Davidoff A. 121 Hypomethylating Agent Therapy Use and Survival in Older Patients with Higher Risk Myelodysplastic Syndromes in USA: A Large Population-Based Study. Leukemia Research 2017, 55: s75-s76. DOI: 10.1016/s0145-2126(17)30234-5.
• The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive ImpairmentViola A, Balsamo L, Neglia JP, Brouwers P, Ma X, Kadan-Lottick NS. The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment. Journal Of Pediatric Hematology/Oncology 2017, 39: 174-178. PMID: 28085741, PMCID: PMC5364064, DOI: 10.1097/mph.0000000000000761.
• Cesarean Section and Risk of Childhood Acute Lymphoblastic Leukemia in a Population-Based, Record-Linkage Study in CaliforniaWang R, Wiemels JL, Metayer C, Morimoto L, Francis SS, Kadan-Lottick N, DeWan AT, Zhang Y, Ma X. Cesarean Section and Risk of Childhood Acute Lymphoblastic Leukemia in a Population-Based, Record-Linkage Study in California. American Journal Of Epidemiology 2016, 185: 96-105. PMID: 27986703, PMCID: PMC5253971, DOI: 10.1093/aje/kww153.
• In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemiaFrancis SS, Wallace AD, Wendt GA, Li L, Liu F, Riley LW, Kogan S, Walsh KM, de Smith AJ, Dahl GV, Ma X, Delwart E, Metayer C, Wiemels JL. In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia. Blood 2016, 129: 1680-1684. PMID: 27979823, PMCID: PMC5364339, DOI: 10.1182/blood-2016-07-723148.
• Hypomethylating Agent Therapy and Survival Among Older Patients with Chronic Myelomonocytic Leukemia in the United States: A Large Population-Based StudyZeidan A, Hu X, Long J, Wang R, Huntington S, Podoltsev N, Gore S, Ma X, Davidoff A. Hypomethylating Agent Therapy and Survival Among Older Patients with Chronic Myelomonocytic Leukemia in the United States: A Large Population-Based Study. Blood 2016, 128: 394. DOI: 10.1182/blood.v128.22.394.394.
• Undertreatment of Patients (Pts) with Myelodysplastic Syndromes (MDS): Analysis of a Large Electronic Medical Records (EMR) Database Cohort of US Pts with MDSSteensma D, Scott B, Ma X, Fliss A, Kiselev P, Swern A, Sugrue M. Undertreatment of Patients (Pts) with Myelodysplastic Syndromes (MDS): Analysis of a Large Electronic Medical Records (EMR) Database Cohort of US Pts with MDS. Blood 2016, 128: 4768. DOI: 10.1182/blood.v128.22.4768.4768.
• Cost-Effectiveness Analysis of Consolidation with Brentuximab Vendotin Versus Active Surveillance in Individuals with High-Risk Hodgkin Lymphoma Undergoing High Dose Chemotherapy with Stem Cell RescueHui L, von Keudell G, Wang R, Zeidan A, Gore S, Ma X, Davidoff A, Huntington S. Cost-Effectiveness Analysis of Consolidation with Brentuximab Vendotin Versus Active Surveillance in Individuals with High-Risk Hodgkin Lymphoma Undergoing High Dose Chemotherapy with Stem Cell Rescue. Blood 2016, 128: 1188. DOI: 10.1182/blood.v128.22.1188.1188.
• Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population‐Based StudyWang R, Zeidan AM, Yu JB, Soulos PR, Davidoff AJ, Gore SD, Huntington SF, Gross CP, Ma X. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population‐Based Study. The Prostate 2016, 77: 437-445. PMID: 27868212, PMCID: PMC5785924, DOI: 10.1002/pros.23281.
• Birth weight and risk of paediatric Hodgkin lymphoma: Findings from a population-based record linkage study in CaliforniaTriebwasser C, Wang R, DeWan AT, Metayer C, Morimoto L, Wiemels JL, Kadan-Lottick N, Ma X. Birth weight and risk of paediatric Hodgkin lymphoma: Findings from a population-based record linkage study in California. European Journal Of Cancer 2016, 69: 19-27. PMID: 27814470, PMCID: PMC5125877, DOI: 10.1016/j.ejca.2016.09.016.
• Unconventional oil and gas development and risk of childhood leukemia: Assessing the evidenceElliott EG, Trinh P, Ma X, Leaderer BP, Ward MH, Deziel NC. Unconventional oil and gas development and risk of childhood leukemia: Assessing the evidence. The Science Of The Total Environment 2016, 576: 138-147. PMID: 27783932, PMCID: PMC6457992, DOI: 10.1016/j.scitotenv.2016.10.072.
• Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark surveyMesa RA, Miller CB, Thyne M, Mangan J, Goldberger S, Fazal S, Ma X, Wilson W, Paranagama DC, Dubinski DG, Naim A, Parasuraman S, Boyle J, Mascarenhas JO. Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. Cancer 2016, 123: 449-458. PMID: 27690182, PMCID: PMC5297986, DOI: 10.1002/cncr.30325.
• Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromesZeidan AM, Davidoff AJ, Long JB, Hu X, Wang R, Ma X, Gross CP, Abel GA, Huntington SF, Podoltsev NA, Hajime U, Prebet T, Gore SD. Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes. British Journal Of Haematology 2016, 175: 829-840. PMID: 27650975, DOI: 10.1111/bjh.14305.
• Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United StatesZeidan AM, Wang R, Gross CP, Gore SD, Huntington SF, Prebet T, Abel GA, Davidoff AJ, Ma X. Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States. Leukemia & Lymphoma 2016, 58: 982-985. PMID: 27558206, DOI: 10.1080/10428194.2016.1214954.
• Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort studySteensma DP, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, George TI, Grinblatt D, Komrokji R, Ma X, Maciejewski J, Pollyea DA, Savona MR, Scott B, Sekeres MA, Thompson MA, Swern AS, Nifenecker M, Sugrue MM, Erba H. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study. BMC Cancer 2016, 16: 652. PMID: 27538433, PMCID: PMC4991094, DOI: 10.1186/s12885-016-2710-6.
• Assessing the potential link between chemical exposures from unconventional oil and gas development and risk of childhood leukemiaElliott* E, Trinh P, Ma X, Leaderer B, Ward M, Deziel N. Assessing the potential link between chemical exposures from unconventional oil and gas development and risk of childhood leukemia. ISEE Conference Abstracts 2016, 2016 DOI: 10.1289/isee.2016.4602.
• Abstract 1777: Prostate cancer risk factor profiles in black and white men in the NIH-AARP Diet and Health StudyLayne T, Graubard B, Ma X, Mayne S, Albanes D. Abstract 1777: Prostate cancer risk factor profiles in black and white men in the NIH-AARP Diet and Health Study. Cancer Research 2016, 76: 1777-1777. DOI: 10.1158/1538-7445.am2016-1777.
• Air toxics and early childhood acute lymphocytic leukemia in Texas, a population based case control studySymanski E, Tee Lewis PG, Chen TY, Chan W, Lai D, Ma X. Air toxics and early childhood acute lymphocytic leukemia in Texas, a population based case control study. Environmental Health 2016, 15: 70. PMID: 27301866, PMCID: PMC4908700, DOI: 10.1186/s12940-016-0154-8.
• Factors affecting time to active therapy (AT) among patients (pts) with myelodysplastic syndromes (MDS) in a US electronic medical records (EMR) database.Scott B, Kiselev P, Fliss A, Huang M, Steensma D, Ma X, Swern A, Sugrue M. Factors affecting time to active therapy (AT) among patients (pts) with myelodysplastic syndromes (MDS) in a US electronic medical records (EMR) database. Journal Of Clinical Oncology 2016, 34: e18548-e18548. DOI: 10.1200/jco.2016.34.15_suppl.e18548.
• Randomized trial assessing the impact of survivorship care plans on the quality of care for childhood cancer survivors.Gross C, Ross W, Rotatori J, Mitchell H, Ma X, Kadan-Lottick N. Randomized trial assessing the impact of survivorship care plans on the quality of care for childhood cancer survivors. Journal Of Clinical Oncology 2016, 34: 10007-10007. DOI: 10.1200/jco.2016.34.15_suppl.10007.
• Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level AnalysisWang SY, Hsu SH, Gross CP, Sanft T, Davidoff AJ, Ma X, Yu JB. Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis. Value In Health 2016, 19: 631-638. PMID: 27565280, PMCID: PMC5002308, DOI: 10.1016/j.jval.2016.02.010.
• Disease‐related costs of care and survival among Medicare‐enrolled patients with myelodysplastic syndromesZeidan AM, Wang R, Davidoff AJ, Ma S, Zhao Y, Gore SD, Gross CP, Ma X. Disease‐related costs of care and survival among Medicare‐enrolled patients with myelodysplastic syndromes. Cancer 2016, 122: 1598-1607. PMID: 26970288, PMCID: PMC5509410, DOI: 10.1002/cncr.29945.
• Abstract C41: Serum vitamin D and risk of prostate cancer among black men in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialLayne T, Weinstein S, Ma X, Graubard B, Mayne S, Albanes D. Abstract C41: Serum vitamin D and risk of prostate cancer among black men in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiology Biomarkers & Prevention 2016, 25: c41-c41. DOI: 10.1158/1538-7755.disp15-c41.
• Stressful exit from the womb and risk of childhood leukaemiaWiemels J, Ma X. Stressful exit from the womb and risk of childhood leukaemia. The Lancet Haematology 2016, 3: e155-e156. PMID: 27063969, DOI: 10.1016/s2352-3026(16)00019-3.
• Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark surveyMesa R, Miller CB, Thyne M, Mangan J, Goldberger S, Fazal S, Ma X, Wilson W, Paranagama DC, Dubinski DG, Boyle J, Mascarenhas JO. Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark survey. BMC Cancer 2016, 16: 167. PMID: 26922064, PMCID: PMC4769833, DOI: 10.1186/s12885-016-2208-2.
• Birth weight, fetal growth, and risk of pediatric rhabdomyosarcoma: an updated record linkage study in CaliforniaMorimoto LM, McCauley K, Ma X, Wiemels JL, Chokkalingam AP, Metayer C. Birth weight, fetal growth, and risk of pediatric rhabdomyosarcoma: an updated record linkage study in California. Annals Of Epidemiology 2015, 26: 141-145. PMID: 26795698, DOI: 10.1016/j.annepidem.2015.11.007.
• Comparative Effectiveness of Azacitidine Versus Decitabine Among Older Adults Diagnosed with Higher-Risk Myelodysplastic Syndromes (HR-MDS)Zeidan A, Long J, Hall J, Wang R, Huntington S, Abel G, Prebet T, Podoltsev N, Gross C, Gore S, Ma X, Davidoff A. Comparative Effectiveness of Azacitidine Versus Decitabine Among Older Adults Diagnosed with Higher-Risk Myelodysplastic Syndromes (HR-MDS). Blood 2015, 126: 3285. DOI: 10.1182/blood.v126.23.3285.3285.
• Secondary Myeloid Neoplasms in Older Women with Breast Cancer after Radiotherapy: A Population-Based StudyZeidan A, Long J, Wang R, Yu J, Hall J, Abel G, Gore S, Gross C, Ma X, Davidoff A. Secondary Myeloid Neoplasms in Older Women with Breast Cancer after Radiotherapy: A Population-Based Study. Blood 2015, 126: 1676. DOI: 10.1182/blood.v126.23.1676.1676.
• Use of an Electronic Medical Record (EMR) Database to Identify a Real-World Cohort of US Patients (Pts) with Myelodysplastic Syndromes (MDS)Ma X, Swern A, Kiselev P, Fliss A, Lu J, Scott B, Steensma D, Sugrue M. Use of an Electronic Medical Record (EMR) Database to Identify a Real-World Cohort of US Patients (Pts) with Myelodysplastic Syndromes (MDS). Blood 2015, 126: 3319. DOI: 10.1182/blood.v126.23.3319.3319.
• Myelodysplastic Syndromes and Acute Myeloid Leukemia in Prostate Cancer Patients after Radiotherapy, a Population-Based StudyWang R, Zeidan A, Soulos P, Yu J, Davidoff A, Gore S, Gross C, Ma X. Myelodysplastic Syndromes and Acute Myeloid Leukemia in Prostate Cancer Patients after Radiotherapy, a Population-Based Study. Blood 2015, 126: 3295. DOI: 10.1182/blood.v126.23.3295.3295.
• Lack of Association Between Costs of Care and Overall Survival (OS) Among Medicare Beneficiaries with Myelodysplastic Syndromes (MDS) in the United States (US)Zeidan A, Wang R, Davidoff A, Gore S, Soulos P, Huntington S, Gross C, Ma X. Lack of Association Between Costs of Care and Overall Survival (OS) Among Medicare Beneficiaries with Myelodysplastic Syndromes (MDS) in the United States (US). Blood 2015, 126: 873. DOI: 10.1182/blood.v126.23.873.873.
• A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal EvolutionWalsh KM, de Smith AJ, Hansen HM, Smirnov IV, Gonseth S, Endicott AA, Xiao J, Rice T, Fu CH, McCoy LS, Lachance DH, Eckel-Passow JE, Wiencke JK, Jenkins RB, Wrensch MR, Ma X, Metayer C, Wiemels JL. A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution. Cancer Research 2015, 75: 4884-4894. PMID: 26527286, PMCID: PMC4651745, DOI: 10.1158/0008-5472.can-15-1105.
• Disease-specific costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes (MDS)Zeidan A, Wang R, Davidoff A, Gore S, Gross C, Ma X. Disease-specific costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes (MDS). Clinical Lymphoma Myeloma & Leukemia 2015, 15: s44-s45. DOI: 10.1016/j.clml.2015.07.094.
• Organophosphate insecticide use and cancer incidence among spouses of pesticide applicators in the Agricultural Health StudyLerro CC, Koutros S, Andreotti G, Friesen MC, Alavanja MC, Blair A, Hoppin JA, Sandler DP, Lubin JH, Ma X, Zhang Y, Freeman L. Organophosphate insecticide use and cancer incidence among spouses of pesticide applicators in the Agricultural Health Study. Occupational And Environmental Medicine 2015, 72: 736. PMID: 26150671, PMCID: PMC4909328, DOI: 10.1136/oemed-2014-102798.
• The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast CancerXu X, Herrin J, Soulos PR, Saraf A, Roberts KB, Killelea BK, Wang SY, Long JB, Wang R, Ma X, Gross CP. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer. Health Services Research 2015, 51: 167-186. PMID: 26119176, PMCID: PMC4722219, DOI: 10.1111/1475-6773.12328.
• Older Women With Localized Breast Cancer: Costs And Survival Rates Increased Across Two Time PeriodsFeinstein AJ, Long J, Soulos PR, Ma X, Herrin J, Frick KD, Chagpar AB, Krumholz HM, Yu JB, Ross JS, Gross CP. Older Women With Localized Breast Cancer: Costs And Survival Rates Increased Across Two Time Periods. Health Affairs 2015, 34: 592-600. PMID: 25847641, DOI: 10.1377/hlthaff.2014.1119.
• Use of acetochlor and cancer incidence in the Agricultural Health StudyLerro CC, Koutros S, Andreotti G, Hines CJ, Blair A, Lubin J, Ma X, Zhang Y, Beane Freeman L. Use of acetochlor and cancer incidence in the Agricultural Health Study. International Journal Of Cancer 2015, 137: 1167-1175. PMID: 25559664, PMCID: PMC4492894, DOI: 10.1002/ijc.29416.
• Gaps in Perception Between Patients and Physicians Regarding Symptomatology and Treatment Attitudes for Myeloproliferative Neoplasms: MPN LANDMARK SURVEYMesa R, Miller C, Thyne M, Mangan J, Goldberger S, Fazal S, Ma X, Wilson W, Dubinski D, Boyle J, Mascarenhas J. Gaps in Perception Between Patients and Physicians Regarding Symptomatology and Treatment Attitudes for Myeloproliferative Neoplasms: MPN LANDMARK SURVEY. Blood 2014, 124: 4827. DOI: 10.1182/blood.v124.21.4827.4827.
• Impact of Myeloproliferative Neoplasms (MPNs) on Patients’ Overall Health and Productivity: Results from the MPN LANDMARK SURVEY in the United StatesMesa R, Miller C, Thyne M, Mangan J, Goldberger S, Fazal S, Ma X, Wilson W, Dubinski D, Boyle J, Mascarenhas J. Impact of Myeloproliferative Neoplasms (MPNs) on Patients’ Overall Health and Productivity: Results from the MPN LANDMARK SURVEY in the United States. Blood 2014, 124: 3183. DOI: 10.1182/blood.v124.21.3183.3183.
• Disease Risk Estimation by Combining Case–Control Data with Aggregated Information on the Population at RiskChang X, Waagepetersen R, Yu H, Ma X, Holford TR, Wang R, Guan Y. Disease Risk Estimation by Combining Case–Control Data with Aggregated Information on the Population at Risk. Biometrics 2014, 71: 114-121. PMID: 25351292, PMCID: PMC4782587, DOI: 10.1111/biom.12256.
• Birth Weight Reference Percentiles for ChineseDai L, Deng C, Li Y, Zhu J, Mu Y, Deng Y, Mao M, Wang Y, Li Q, Ma S, Ma X, Zhang Y. Birth Weight Reference Percentiles for Chinese. PLOS ONE 2014, 9: e104779. PMID: 25127131, PMCID: PMC4134219, DOI: 10.1371/journal.pone.0104779.
• Understanding Regional Variation in Medicare Expenditures for Initial Episodes of Prostate Cancer CareWang SY, Wang R, Yu JB, Ma X, Xu X, Kim SP, Soulos PR, Saraf A, Gross CP. Understanding Regional Variation in Medicare Expenditures for Initial Episodes of Prostate Cancer Care. Medical Care 2014, 52: 680-687. PMID: 25023913, PMCID: PMC4129645, DOI: 10.1097/mlr.0000000000000158.
• Evolution of Breast Cancer Screening in the Medicare Population: Clinical and Economic ImplicationsKillelea BK, Long JB, Chagpar AB, Ma X, Wang R, Ross JS, Gross CP. Evolution of Breast Cancer Screening in the Medicare Population: Clinical and Economic Implications. Journal Of The National Cancer Institute 2014, 106 PMID: 25031307, PMCID: PMC4155428, DOI: 10.1093/jnci/dju159.
• Connect MDS and AML: The myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) disease registry.Steensma D, Abedi M, Attar E, Bejar R, Cogle C, Garcia-Manero G, Grinblatt D, Ma X, Maciejewski J, Pollyea D, Roboz G, Savona M, Scott B, Sekeres M, Thompson M, Zernovak O, Sugrue M, Swern A, Nifenecker M, Erba H. Connect MDS and AML: The myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) disease registry. Journal Of Clinical Oncology 2014, 32: tps7126-tps7126. DOI: 10.1200/jco.2014.32.15_suppl.tps7126.
• Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B‐cell acute lymphoblastic leukemiaWalsh KM, de Smith A, Welch TC, Smirnov I, Cunningham MJ, Ma X, Chokkalingam AP, Dahl GV, Roberts W, Barcellos LF, Buffler PA, Metayer C, Wiemels JL. Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B‐cell acute lymphoblastic leukemia. American Journal Of Hematology 2014, 89: 721-725. PMID: 24753091, PMCID: PMC4069235, DOI: 10.1002/ajh.23727.
• PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemiaXiao J, Lee S, Xiao Y, Ma X, Houseman EA, Hsu L, Roy R, Wrensch M, de Smith A, Chokkalingam A, Buffler P, Wiencke JK, Wiemels JL. PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia. International Journal Of Cancer 2014, 135: 1101-1109. PMID: 24496747, PMCID: PMC4776754, DOI: 10.1002/ijc.28759.
• A New Estimation Approach for Combining Epidemiological Data From Multiple SourcesHuang H, Ma X, Waagepetersen R, Holford TR, Wang R, Risch H, Mueller L, Guan Y. A New Estimation Approach for Combining Epidemiological Data From Multiple Sources. Journal Of The American Statistical Association 2014, 109: 11-23. PMID: 24683281, PMCID: PMC3964681, DOI: 10.1080/01621459.2013.870904.
• Abstract P6-07-05: Regional variation in Medicare expenditures for older women with localized breast cancerXu X, Soulos P, Herrin J, Ross J, Saraf A, Roberts K, Killelea B, Wang S, Long J, Wang R, Ma X, Gross C. Abstract P6-07-05: Regional variation in Medicare expenditures for older women with localized breast cancer. Cancer Research 2013, 73: p6-07-05-p6-07-05. DOI: 10.1158/0008-5472.sabcs13-p6-07-05.
• The cost implications of prostate cancer screening in the Medicare populationMa X, Wang R, Long JB, Ross JS, Soulos PR, Yu JB, Makarov DV, Gold HT, Gross CP. The cost implications of prostate cancer screening in the Medicare population. Cancer 2013, 120: 96-102. PMID: 24122801, PMCID: PMC3867600, DOI: 10.1002/cncr.28373.
• Tobacco Smoke Exposure and the Risk of Childhood Acute Lymphoblastic and Myeloid Leukemias by Cytogenetic SubtypeMetayer C, Zhang L, Wiemels JL, Bartley K, Schiffman J, Ma X, Aldrich MC, Chang JS, Selvin S, Fu CH, Ducore J, Smith MT, Buffler PA. Tobacco Smoke Exposure and the Risk of Childhood Acute Lymphoblastic and Myeloid Leukemias by Cytogenetic Subtype. Cancer Epidemiology Biomarkers & Prevention 2013, 22: 1600-1611. PMID: 23853208, PMCID: PMC3769478, DOI: 10.1158/1055-9965.epi-13-0350.
• Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancerKillelea BK, Long JB, Chagpar AB, Ma X, Soulos PR, Ross JS, Gross CP. Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer. Breast Cancer Research And Treatment 2013, 141: 155-163. PMID: 23942872, PMCID: PMC3893026, DOI: 10.1007/s10549-013-2656-1.
• The cost implications of prostate cancer screening in the Medicare population.Ma X, Wang R, Long J, Ross J, Soulos P, Yu J, Makarov D, Gold H, Gross C. The cost implications of prostate cancer screening in the Medicare population. Journal Of Clinical Oncology 2013, 31: 6549-6549. DOI: 10.1200/jco.2013.31.15_suppl.6549.
• Health practices and behaviors of childhood cancer survivors not attending a comprehensive survivor clinic.Iyer N, Mitchell H, Gross C, Ma X, Kadan-Lottick N. Health practices and behaviors of childhood cancer survivors not attending a comprehensive survivor clinic. Journal Of Clinical Oncology 2013, 31: 10063-10063. DOI: 10.1200/jco.2013.31.15_suppl.10063.
• Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic childrenWalsh KM, Chokkalingam AP, Hsu LI, Metayer C, de Smith AJ, Jacobs DI, Dahl GV, Loh ML, Smirnov IV, Bartley K, Ma X, Wiencke JK, Barcellos LF, Wiemels JL, Buffler PA. Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children. Leukemia 2013, 27: 2416-2419. PMID: 23615557, PMCID: PMC3864612, DOI: 10.1038/leu.2013.130.
• The Cost of Breast Cancer Screening in the Medicare PopulationGross CP, Long JB, Ross JS, Abu-Khalaf MM, Wang R, Killelea BK, Gold HT, Chagpar AB, Ma X. The Cost of Breast Cancer Screening in the Medicare Population. JAMA Internal Medicine 2013, 173: 220-226. PMID: 23303200, PMCID: PMC3638736, DOI: 10.1001/jamainternmed.2013.1397.
• Impact of the 2008 US Preventive Services Task Force Recommendation to Discontinue Prostate Cancer Screening Among Male Medicare BeneficiariesRoss JS, Wang R, Long JB, Gross CP, Ma X. Impact of the 2008 US Preventive Services Task Force Recommendation to Discontinue Prostate Cancer Screening Among Male Medicare Beneficiaries. JAMA Internal Medicine 2012, 172: 1601-1603. PMID: 22987029, PMCID: PMC3597450, DOI: 10.1001/archinternmed.2012.3726.
• A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor networkLee ST, Xiao Y, Muench MO, Xiao J, Fomin ME, Wiencke JK, Zheng S, Dou X, de Smith A, Chokkalingam A, Buffler P, Ma X, Wiemels JL. A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network. Nucleic Acids Research 2012, 40: 11339-11351. PMID: 23074194, PMCID: PMC3526268, DOI: 10.1093/nar/gks957.
• New health conditions identified at a regional childhood cancer survivor clinic visitHogan M, Ma X, Kadan‐Lottick N. New health conditions identified at a regional childhood cancer survivor clinic visit. Pediatric Blood & Cancer 2012, 60: 682-687. PMID: 23023769, DOI: 10.1002/pbc.24360.
• HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia riskUrayama KY, Chokkalingam AP, Metayer C, Ma X, Selvin S, Barcellos LF, Wiemels JL, Wiencke JK, Taylor M, Brennan P, Dahl GV, Moonsamy P, Erlich HA, Trachtenberg E, Buffler PA. HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk. Blood 2012, 120: 3039-3047. PMID: 22923493, PMCID: PMC3471514, DOI: 10.1182/blood-2012-01-404723.
• The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromesWang R, Gross CP, Frick K, Xu X, Long J, Raza A, Galili N, Zikria J, Guan Y, Ma X. The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes. Leukemia Research 2012, 36: 1370-1375. PMID: 22917770, PMCID: PMC3458648, DOI: 10.1016/j.leukres.2012.07.020.
• Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemiaChokkalingam AP, Metayer C, Scelo G, Chang JS, Schiffman J, Urayama KY, Ma X, Hansen HM, Feusner JH, Barcellos LF, Wiencke JK, Wiemels JL, Buffler PA. Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemia. Cancer Causes & Control 2012, 23: 1577-1585. PMID: 22878902, PMCID: PMC3415610, DOI: 10.1007/s10552-012-0035-6.
• Patterns of subsequent malignancies after Hodgkin lymphoma in children and adultsOmer B, Kadan‐Lottick N, Roberts KB, Wang R, Demsky C, Kupfer GM, Cooper D, Seropian S, Ma X. Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults. British Journal Of Haematology 2012, 158: 615-625. PMID: 22775513, DOI: 10.1111/j.1365-2141.2012.09211.x.
• Epidemiology of Myelodysplastic SyndromesMa X. Epidemiology of Myelodysplastic Syndromes. The American Journal Of Medicine 2012, 125: s2-s5. PMID: 22735748, PMCID: PMC3394456, DOI: 10.1016/j.amjmed.2012.04.014.
• The evolution of breast cancer screening in the Medicare population: Clinical and economic implications.Killelea B, Long J, Ma X, Wang R, Chagpar A, Ross J, Gross C. The evolution of breast cancer screening in the Medicare population: Clinical and economic implications. Journal Of Clinical Oncology 2012, 30: 1595-1595. DOI: 10.1200/jco.2012.30.15_suppl.1595.
• Regional variation in treatment costs and survival for elderly patients with myelodysplastic syndromes.Ma X, Wang R, Long J, Gold H, Halene S, Gross C. Regional variation in treatment costs and survival for elderly patients with myelodysplastic syndromes. Journal Of Clinical Oncology 2012, 30: 6628-6628. DOI: 10.1200/jco.2012.30.15_suppl.6628.
• Response to a treatment summary and care plan among adult survivors of pediatric and young adult cancer.Spain PD, Oeffinger KC, Candela J, McCabe M, Ma X, Tonorezos ES. Response to a treatment summary and care plan among adult survivors of pediatric and young adult cancer. Journal Of Oncology Practice / American Society Of Clinical Oncology 2012, 8: 196-202. PMID: 22942816, PMCID: PMC3396810, DOI: 10.1200/JOP.2011.000345.
• Methyl bromide exposure and cancer risk in the Agricultural Health StudyBarry KH, Koutros S, Lubin JH, Coble JB, Barone-Adesi F, Beane Freeman LE, Sandler DP, Hoppin JA, Ma X, Zheng T, Alavanja MC. Methyl bromide exposure and cancer risk in the Agricultural Health Study. Cancer Causes & Control 2012, 23: 807-818. PMID: 22527160, PMCID: PMC3430844, DOI: 10.1007/s10552-012-9949-2.
• Abstract 662: Effect of tobacco smoking on the risks of childhood acute lymphocytic and myeloid leukemias, by phenotypic and cytogenetic subtypeMetayer C, Zhang L, Wiemels J, Bartley K, Schiffman J, Ma X, Aldrich M, Selvin S, Smith M, Buffler P. Abstract 662: Effect of tobacco smoking on the risks of childhood acute lymphocytic and myeloid leukemias, by phenotypic and cytogenetic subtype. Cancer Research 2012, 72: 662-662. DOI: 10.1158/1538-7445.am2012-662.
• Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer riskBarry KH, Koutros S, Andreotti G, Sandler DP, Burdette LA, Yeager M, Freeman L, Lubin JH, Ma X, Zheng T, Alavanja MC, Berndt SI. Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk. Carcinogenesis 2011, 33: 331-337. PMID: 22102698, PMCID: PMC3271261, DOI: 10.1093/carcin/bgr258.
• Abstract B51: Genetic variation in nucleotide excision repair pathway genes, pesticide exposure, and prostate cancer riskBarry K, Zheng T, Alavanja M, Berndt S, Koutros S, Andreotti G, Sandler D, Burdette L, Yeager M, Freeman L, Lubin J, Ma X. Abstract B51: Genetic variation in nucleotide excision repair pathway genes, pesticide exposure, and prostate cancer risk. Cancer Prevention Research 2011, 4: b51-b51. DOI: 10.1158/1940-6207.prev-11-b51.
• Genetic Variation in Base Excision Repair Pathway Genes, Pesticide Exposure, and Prostate Cancer RiskBarry KH, Koutros S, Berndt SI, Andreotti G, Hoppin JA, Sandler DP, Burdette LA, Yeager M, Freeman LE, Lubin JH, Ma X, Zheng T, Alavanja MC. Genetic Variation in Base Excision Repair Pathway Genes, Pesticide Exposure, and Prostate Cancer Risk. Environmental Health Perspectives 2011, 119: 1726-1732. PMID: 21810555, PMCID: PMC3261977, DOI: 10.1289/ehp.1103454.
• Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromesMa X, Wang R, Galili N, Mayne ST, Wang SA, Yu H, Raza A. Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes. Cancer Causes & Control 2011, 22: 623-629. PMID: 21287258, PMCID: PMC3086405, DOI: 10.1007/s10552-011-9735-6.
• Ascertainment of patients with myelodysplastic syndromes.Ma X, Wang R. Ascertainment of patients with myelodysplastic syndromes. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2011, 29: e16; author reply e17. PMID: 21079144, DOI: 10.1200/JCO.2010.31.8287.
• Early life exposure to infections and risk of childhood acute lymphoblastic leukemiaUrayama KY, Ma X, Selvin S, Metayer C, Chokkalingam AP, Wiemels JL, Does M, Chang J, Wong A, Trachtenberg E, Buffler PA. Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. International Journal Of Cancer 2010, 128: 1632-1643. PMID: 21280034, PMCID: PMC3165002, DOI: 10.1002/ijc.25752.
• Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromesWang R, Gross CP, Maggiore RJ, Halene S, Soulos PR, Raza A, Galili N, Ma X. Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes. Leukemia Research 2010, 35: 904-908. PMID: 21067809, PMCID: PMC3114277, DOI: 10.1016/j.leukres.2010.10.007.
• Xenobiotic Metabolizing Genes, Meat-Related Exposures, and Risk of Advanced Colorectal AdenomaFerrucci LM, Cross AJ, Gunter MJ, Ahn J, Mayne ST, Ma X, Chanock SJ, Yeager M, Graubard BI, Berndt SI, Huang WY, Hayes RB, Sinha R. Xenobiotic Metabolizing Genes, Meat-Related Exposures, and Risk of Advanced Colorectal Adenoma. 2010, 101: 34-45. PMID: 20436251, PMCID: PMC3051350, DOI: 10.1159/000314509.
• A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemiaUrayama KY, Buffler PA, Gallagher ER, Ayoob JM, Ma X. A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. International Journal Of Epidemiology 2010, 39: 718-732. PMID: 20110276, PMCID: PMC2878455, DOI: 10.1093/ije/dyp378.
• Xenobiotic Metabolizing Genes, Meat-Related Exposures, and Risk of Advanced Colorectal AdenomaFerrucci LM, Cross AJ, Gunter MJ, Ahn J, Mayne ST, Ma X, Chanock SJ, Yeager M, Graubard BI, Berndt SI, Huang WY, Hayes RB, Sinha R. Xenobiotic Metabolizing Genes, Meat-Related Exposures, and Risk of Advanced Colorectal Adenoma. Lifestyle Genomics 2010, 3: 170-181. PMID: 21474949, PMCID: PMC3085523, DOI: 10.1159/000324351.
• Diet, Lifestyle, and Acute Myeloid Leukemia in the NIH–AARP CohortMa X, Park Y, Mayne ST, Wang R, Sinha R, Hollenbeck AR, Schatzkin A, Cross AJ. Diet, Lifestyle, and Acute Myeloid Leukemia in the NIH–AARP Cohort. American Journal Of Epidemiology 2009, 171: 312-322. PMID: 20042434, PMCID: PMC2842202, DOI: 10.1093/aje/kwp371.
• Energy Intake and Risk of Postmenopausal Breast Cancer: An Expanded Analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) CohortSue LY, Schairer C, Ma X, Williams C, Chang SC, Miller AB, McCarty CA, Willcox BJ, Ziegler RG. Energy Intake and Risk of Postmenopausal Breast Cancer: An Expanded Analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort. Cancer Epidemiology Biomarkers & Prevention 2009, 18: 2842-2850. PMID: 19843674, PMCID: PMC2783562, DOI: 10.1158/1055-9965.epi-09-0087.
• Clarification on the categorization of comorbiditiesWang R, Ma X. Clarification on the categorization of comorbidities. Leukemia Research 2009, 34: e74. PMID: 19783302, PMCID: PMC2815216, DOI: 10.1016/j.leukres.2009.08.036.
• Cancer Incidence Among Pesticide Applicators Exposed to Methyl Bromide in the AHSHughes K, Koutros S, Coble J, Lubin J, Freeman L, Sandler D, Hoppin J, Ma X, Zheng T, Alavanja M. Cancer Incidence Among Pesticide Applicators Exposed to Methyl Bromide in the AHS. Annals Of Epidemiology 2009, 19: 662-663. DOI: 10.1016/j.annepidem.2009.07.055.
• Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialFerrucci LM, Cross AJ, Graubard BI, Brinton LA, McCarty CA, Ziegler RG, Ma X, Mayne ST, Sinha R. Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. British Journal Of Cancer 2009, 101: 178-184. PMID: 19513076, PMCID: PMC2713710, DOI: 10.1038/sj.bjc.6605118.
• Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United StatesWang R, Gross CP, Halene S, Ma X. Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States. Cancer Causes & Control 2009, 20: 1369-1376. PMID: 19455395, PMCID: PMC2921772, DOI: 10.1007/s10552-009-9362-7.
• Obesity, Lifestyle Factors, and Risk of Myelodysplastic Syndromes in a Large US CohortMa X, Lim U, Park Y, Mayne ST, Wang R, Hartge P, Hollenbeck AR, Schatzkin A. Obesity, Lifestyle Factors, and Risk of Myelodysplastic Syndromes in a Large US Cohort. American Journal Of Epidemiology 2009, 169: 1492-1499. PMID: 19395696, PMCID: PMC2727203, DOI: 10.1093/aje/kwp074.
• Dietary Meat Intake in Relation to Colorectal Adenoma in Asymptomatic WomenFerrucci LM, Sinha R, Graubard BI, Mayne ST, Ma X, Schatzkin A, Schoenfeld PS, Cash BD, Flood A, Cross AJ. Dietary Meat Intake in Relation to Colorectal Adenoma in Asymptomatic Women. The American Journal Of Gastroenterology 2009, 104: ajg2009102. PMID: 19367270, PMCID: PMC2891034, DOI: 10.1038/ajg.2009.102.
• Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromesWang R, Gross CP, Halene S, Ma X. Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes. Leukemia Research 2009, 33: 1594-1598. PMID: 19324411, PMCID: PMC2749891, DOI: 10.1016/j.leukres.2009.02.005.
• Xenobiotic Metabolizing Gene Variants, Dietary Heterocyclic Amine Intake, and Risk of Prostate CancerKoutros S, Berndt SI, Sinha R, Ma X, Chatterjee N, Alavanja MC, Zheng T, Huang WY, Hayes RB, Cross AJ. Xenobiotic Metabolizing Gene Variants, Dietary Heterocyclic Amine Intake, and Risk of Prostate Cancer. Cancer Research 2009, 69: 1877-1884. PMID: 19223546, PMCID: PMC2662592, DOI: 10.1158/0008-5472.can-08-2447.
• Jakking up tumor registry reporting of the myeloproliferative neoplasmsSelinger HA, Ma X. Jakking up tumor registry reporting of the myeloproliferative neoplasms. American Journal Of Hematology 2008, 84: 124-126. PMID: 19117021, DOI: 10.1002/ajh.21333.
• Infection and pediatric acute lymphoblastic leukemiaMa X, Urayama K, Chang J, Wiemels JL, Buffler PA. Infection and pediatric acute lymphoblastic leukemia. Blood Cells Molecules And Diseases 2008, 42: 117-120. PMID: 19064328, PMCID: PMC2834409, DOI: 10.1016/j.bcmd.2008.10.006.
• Heterocyclic aromatic amine pesticide use and human cancer risk: Results from the U.S. Agricultural Health StudyKoutros S, Lynch CF, Ma X, Lee WJ, Hoppin JA, Christensen CH, Andreotti G, Freeman LB, Rusiecki JA, Hou L, Sandler DP, Alavanja MC. Heterocyclic aromatic amine pesticide use and human cancer risk: Results from the U.S. Agricultural Health Study. International Journal Of Cancer 2008, 124: 1206-1212. PMID: 19058219, PMCID: PMC2904521, DOI: 10.1002/ijc.24020.
• Abstract B129: Xenobiotic metabolizing genes, meat intake and risk of advanced colorectal adenomaFerrucci L, Cross A, Gunter M, Ahn J, Mayne S, Ma X, Chanock S, Yeager M, Graubard B, Berndt S, Huang W, Hayes R, Sinha R. Abstract B129: Xenobiotic metabolizing genes, meat intake and risk of advanced colorectal adenoma. Cancer Prevention Research 2008, 1: b129-b129. DOI: 10.1158/1940-6207.prev-08-b129.
• Exposure to infections through day-care attendance and risk of childhood leukaemia.Urayama KY, Ma X, Buffler PA. Exposure to infections through day-care attendance and risk of childhood leukaemia. Radiation Protection Dosimetry 2008, 132: 259-66. PMID: 18940822, PMCID: PMC2879097, DOI: 10.1093/rpd/ncn271.
• Aromatic Amine Pesticide Use And Human Cancer Risk: Results From The U.S. Agricultural Health StudyKoutros S, Lynch C, Ma X, Lee W, Hoppin J, Christensen C, Andreotti G, Freeman L, Rusiecki J, Hou L, Sandler D, Alavanja M. Aromatic Amine Pesticide Use And Human Cancer Risk: Results From The U.S. Agricultural Health Study. Annals Of Epidemiology 2008, 18: 720. DOI: 10.1016/j.annepidem.2008.08.043.
• Prevalence of polycythemia vera and essential thrombocythemiaMa X, Vanasse G, Cartmel B, Wang Y, Selinger HA. Prevalence of polycythemia vera and essential thrombocythemia. American Journal Of Hematology 2008, 83: 359-362. PMID: 18181200, DOI: 10.1002/ajh.21129.
• Meat and Meat Mutagens and Risk of Prostate Cancer in the Agricultural Health StudyKoutros S, Cross AJ, Sandler DP, Hoppin JA, Ma X, Zheng T, Alavanja MC, Sinha R. Meat and Meat Mutagens and Risk of Prostate Cancer in the Agricultural Health Study. Cancer Epidemiology Biomarkers & Prevention 2008, 17: 80-87. PMID: 18199713, PMCID: PMC2935655, DOI: 10.1158/1055-9965.epi-07-0392.
• Incidence of Polycythemia Vera in the Elderly.Ma X, Selinger H, Wang Y, Cartmel B. Incidence of Polycythemia Vera in the Elderly. Blood 2007, 110: 4668. DOI: 10.1182/blood.v110.11.4668.4668.
• Prevalence of Polycythemia Vera and Essential Thrombocythemia.Ma X, Vanasse K, Selinger H, Wang Y, Cartmel B. Prevalence of Polycythemia Vera and Essential Thrombocythemia. Blood 2007, 110: 4667. DOI: 10.1182/blood.v110.11.4667.4667.
• Dichlorvos exposure and human cancer risk: results from the Agricultural Health StudyKoutros S, Mahajan R, Zheng T, Hoppin JA, Ma X, Lynch CF, Blair A, Alavanja MC. Dichlorvos exposure and human cancer risk: results from the Agricultural Health Study. Cancer Causes & Control 2007, 19: 59-65. PMID: 17943454, PMCID: PMC2822646, DOI: 10.1007/s10552-007-9070-0.
• Clustering in the incidence of myelodysplastic syndromesMa X, Selvin S, Raza A, Foti K, Mayne ST. Clustering in the incidence of myelodysplastic syndromes. Leukemia Research 2007, 31: 1683-1686. PMID: 17507092, DOI: 10.1016/j.leukres.2007.03.032.
• Myelodysplastic syndromesMa X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes. Cancer 2007, 109: 1536-1542. PMID: 17345612, DOI: 10.1002/cncr.22570.
• Global burden of cancer.Ma X, Yu H. Global burden of cancer. The Yale Journal Of Biology And Medicine 2006, 79: 85-94. PMID: 17940618, PMCID: PMC1994799.
• Cytogenetics of Hispanic and White Children with Acute Lymphoblastic Leukemia in CaliforniaAldrich MC, Zhang L, Wiemels JL, Ma X, Loh ML, Metayer C, Selvin S, Feusner J, Smith MT, Buffler PA. Cytogenetics of Hispanic and White Children with Acute Lymphoblastic Leukemia in California. Cancer Epidemiology Biomarkers & Prevention 2006, 15: 578-581. PMID: 16537719, DOI: 10.1158/1055-9965.epi-05-0833.
• Cytogenetics of Hispanics and Whites with Childhood Acute Lymphoblastic Leukemia in California.Aldrich M, Zhang L, Wiemels J, Ma X, Loh M, Selvin S, Feusner J, Smith M, Buffler P. Cytogenetics of Hispanics and Whites with Childhood Acute Lymphoblastic Leukemia in California. Blood 2005, 106: 4536. DOI: 10.1182/blood.v106.11.4536.4536.
• Maternal Pregnancy Loss, Birth Characteristics, and Childhood Leukemia (United States)Ma X, Metayer C, Does MB, Buffler PA. Maternal Pregnancy Loss, Birth Characteristics, and Childhood Leukemia (United States). Cancer Causes & Control 2005, 16: 1075-1083. PMID: 16184473, DOI: 10.1007/s10552-005-0356-9.
• Molecular biomarkers for the study of childhood leukemiaSmith MT, McHale CM, Wiemels JL, Zhang L, Wiencke JK, Zheng S, Gunn L, Skibola CF, Ma X, Buffler PA. Molecular biomarkers for the study of childhood leukemia. Toxicology And Applied Pharmacology 2005, 206: 237-245. PMID: 15967214, DOI: 10.1016/j.taap.2004.11.026.
• Ethnic Difference in Daycare Attendance, Early Infections, and Risk of Childhood Acute Lymphoblastic LeukemiaMa X, Buffler PA, Wiemels JL, Selvin S, Metayer C, Loh M, Does MB, Wiencke JK. Ethnic Difference in Daycare Attendance, Early Infections, and Risk of Childhood Acute Lymphoblastic Leukemia. Cancer Epidemiology Biomarkers & Prevention 2005, 14: 1928-1934. PMID: 16103439, DOI: 10.1158/1055-9965.epi-05-0115.
• 408: Ethnic Difference in Daycare Attendance, Early Infections, and Risk of Childhood Acute Lymphoblastic LeukemiaMa X, Buffler P, Wiemels J, Selvin S, Loh M, Metayer C, Does M, Wiencke J. 408: Ethnic Difference in Daycare Attendance, Early Infections, and Risk of Childhood Acute Lymphoblastic Leukemia. American Journal Of Epidemiology 2005, 161: s102-s102. DOI: 10.1093/aje/161.supplement_1.s102c.
• Vaccination history and risk of childhood leukaemiaMa X, Does MB, Metayer C, Russo C, Wong A, Buffler PA. Vaccination history and risk of childhood leukaemia. International Journal Of Epidemiology 2005, 34: 1100-1109. PMID: 15951359, DOI: 10.1093/ije/dyi113.
• RAS mutation is associated with hyperdiploidy and parental characteristics in pediatric acute lymphoblastic leukemiaWiemels JL, Zhang Y, Chang J, Zheng S, Metayer C, Zhang L, Smith MT, Ma X, Selvin S, Buffler PA, Wiencke JK. RAS mutation is associated with hyperdiploidy and parental characteristics in pediatric acute lymphoblastic leukemia. Leukemia 2005, 19: 415-419. PMID: 15674422, DOI: 10.1038/sj.leu.2403641.
• Maternal Dietary Risk Factors in Childhood Acute Lymphoblastic Leukemia (United States)Jensen CD, Block G, Buffler P, Ma X, Selvin S, Month S. Maternal Dietary Risk Factors in Childhood Acute Lymphoblastic Leukemia (United States). Cancer Causes & Control 2004, 15: 559-570. PMID: 15280635, DOI: 10.1023/b:caco.0000036161.98734.17.
• Ma et al. Respond to “Birth Certificates—A Best Control Scenario?”Ma X, Buffler P, Layefsky M, Does M, Reynolds P. Ma et al. Respond to “Birth Certificates—A Best Control Scenario?”. American Journal Of Epidemiology 2004, 159: 925-925. DOI: 10.1093/aje/kwh138.
• Control Selection Strategies in Case-Control Studies of Childhood DiseasesMa X, Buffler PA, Layefsky M, Does MB, Reynolds P. Control Selection Strategies in Case-Control Studies of Childhood Diseases. American Journal Of Epidemiology 2004, 159: 915-921. PMID: 15128601, DOI: 10.1093/aje/kwh136.
• Hypermethylation of the 5′ CpG Island of the FHIT Gene Is Associated with Hyperdiploid and Translocation-Negative Subtypes of Pediatric LeukemiaZheng S, Ma X, Zhang L, Gunn L, Smith MT, Wiemels JL, Leung K, Buffler PA, Wiencke JK. Hypermethylation of the 5′ CpG Island of the FHIT Gene Is Associated with Hyperdiploid and Translocation-Negative Subtypes of Pediatric Leukemia. Cancer Research 2004, 64: 2000-2006. PMID: 15026336, DOI: 10.1158/0008-5472.can-03-2387.
• Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16)McHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Feusner J, Matthay K, Dahl G, Smith MT. Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16). Blood 2003, 101: 4640-4641. PMID: 12756163, DOI: 10.1182/blood-2003-01-0313.
• Prenatal origin of TEL‐AML1–positive acute lymphoblastic leukemia in children born in CaliforniaMcHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Guo W, Loh ML, Smith MT. Prenatal origin of TEL‐AML1–positive acute lymphoblastic leukemia in children born in California. Genes Chromosomes And Cancer 2003, 37: 36-43. PMID: 12661004, DOI: 10.1002/gcc.10199.
• Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemiaWiemels JL, Leonard BC, Wang Y, Segal MR, Hunger SP, Smith MT, Crouse V, Ma X, Buffler PA, Pine SR. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proceedings Of The National Academy Of Sciences Of The United States Of America 2002, 99: 15101-15106. PMID: 12415113, PMCID: PMC137550, DOI: 10.1073/pnas.222481199.
• Critical windows of exposure to household pesticides and risk of childhood leukemia.Ma X, Buffler PA, Gunier RB, Dahl G, Smith MT, Reinier K, Reynolds P. Critical windows of exposure to household pesticides and risk of childhood leukemia. Environmental Health Perspectives 2002, 110: 955-960. PMID: 12204832, PMCID: PMC1240997, DOI: 10.1289/ehp.02110955.
• In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemiaWiemels JL, Xiao Z, Buffler PA, Maia AT, Ma X, Dicks BM, Smith MT, Zhang L, Feusner J, Wiencke J, Pritchard-Jones K, Kempski H, Greaves M. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 2002, 99: 3801-3805. PMID: 11986239, DOI: 10.1182/blood.v99.10.3801.
• Daycare attendance and risk of childhood acute lymphoblastic leukaemiaMa X, Buffler PA, Selvin S, Matthay KK, Wiencke JK, Wiemels JL, Reynolds P. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. British Journal Of Cancer 2002, 86: 1419-1424. PMID: 11986774, PMCID: PMC2375371, DOI: 10.1038/sj.bjc.6600274.
• Whole genome amplification increases the efficiency and validity of buccal cell genotyping in pediatric populations.Zheng S, Ma X, Buffler PA, Smith MT, Wiencke JK. Whole genome amplification increases the efficiency and validity of buccal cell genotyping in pediatric populations. Cancer Epidemiology Biomarkers & Prevention 2001, 10: 697-700. PMID: 11401921.